Report for Combined Biotech 13F Filings for quarter ending on 2025-03-31 (Compiled by @StuckInStock) (Avoro, Baker Brothers, Boxer, BVF, Casdin, Cormorant, Deep Track, EcoR1, Logos, Opaleye, Orbimed, Perceptive, RA Capital, Tang)
Top 40 Stock Holdings by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ASND | 2025-03-31 | Ascendis Pharma A/S | 165.05 | 9,923,581,952.00 | 25.93% | 59,372,631.00 | 2015-01-28 | 2415751447 | 15499496 | 2 | avoro-racapital |
| 1 | INCY | 2025-03-31 | Incyte Corporation | 58.21 | 11,265,032,192.00 | -20.77% | 161,370,279.00 | 1993-11-04 | 1861304154 | 30739953 | 1 | baker |
| 2 | MDGL | 2025-03-31 | Madrigal Pharmaceuticals, Inc. | 301.66 | 6,660,712,960.00 | -1.77% | 11,356,312.00 | 2007-02-06 | 1364108484 | 4118312 | 4 | avoro-baker-ecor1-perceptive |
| 3 | MLTX | 2025-03-31 | MoonLake Immunotherapeutics | 34.90 | 2,208,566,272.00 | -22.88% | 28,073,483.00 | 2020-10-20 | 1225451453 | 31365535 | 4 | avoro-bvf-cormorant-logos |
| 4 | EWTX | 2025-03-31 | Edgewise Therapeutics, Inc. | 11.42 | 1,200,710,272.00 | -54.92% | 54,187,991.00 | 2021-03-26 | 942283584 | 42831072 | 8 | baker-cormorant-deeptrack-perceptive-racapital-orbimed-opaleye-tang |
| 5 | ARGX | 2025-03-31 | argenx SE | 596.20 | 36,474,028,032.00 | -7.91% | 60,989,637.00 | 2017-05-18 | 934641839 | 1579147 | 4 | avoro-baker-perceptive-orbimed |
| 6 | UTHR | 2025-03-31 | United Therapeutics Corporation | 291.38 | 13,312,861,184.00 | -21.15% | 41,324,592.00 | 1999-06-17 | 824622250 | 2675000 | 1 | avoro |
| 7 | RYTM | 2025-03-31 | Rhythm Pharmaceuticals, Inc. | 61.74 | 3,903,431,424.00 | 7.34% | 46,955,630.00 | 2017-10-09 | 808181301 | 15257340 | 6 | baker-cormorant-perceptive-racapital-orbimed-opaleye |
| 8 | ACAD | 2025-03-31 | ACADIA Pharmaceuticals Inc. | 14.73 | 2,456,801,792.00 | -17.66% | 114,380,229.00 | 2004-05-27 | 737117185 | 44377916 | 2 | baker-tang |
| 9 | APLS | 2025-03-31 | Apellis Pharmaceuticals, Inc. | 18.20 | 2,284,391,168.00 | -39.60% | 84,226,131.00 | 2017-11-09 | 668135717 | 30550330 | 4 | avoro-deeptrack-ecor1-orbimed |
| 10 | RVMD | 2025-03-31 | Revolution Medicines, Inc. | 36.76 | 6,834,161,152.00 | -8.47% | 168,212,518.00 | 2020-02-13 | 647699339 | 18317289 | 5 | baker-bvf-casdin-logos-tang |
| 11 | PCVX | 2025-03-31 | Vaxcyte, Inc. | 30.65 | 3,946,555,136.00 | -65.24% | 119,134,116.00 | 2020-06-12 | 595158054 | 15761601 | 7 | avoro-baker-cormorant-deeptrack-perceptive-racapital-tang |
| 12 | RNA | 2025-03-31 | Avidity Biosciences, Inc. | 26.66 | 3,204,851,968.00 | -13.55% | 92,698,110.00 | 2020-06-12 | 563562483 | 19090870 | 7 | avoro-casdin-cormorant-ecor1-logos-racapital-orbimed |
| 13 | INSM | 2025-03-31 | Insmed Incorporated | 72.65 | 13,209,223,168.00 | -5.34% | 166,410,802.00 | 2000-06-01 | 533903054 | 6998336 | 7 | baker-cormorant-deeptrack-perceptive-racapital-orbimed-tang |
| 14 | KRYS | 2025-03-31 | Krystal Biotech, Inc. | 168.57 | 4,871,403,520.00 | 11.23% | 22,823,920.00 | 2017-09-20 | 496636350 | 2754500 | 2 | avoro-orbimed |
| 15 | JANX | 2025-03-31 | Janux Therapeutics, Inc. | 28.80 | 1,702,226,816.00 | -36.09% | 37,290,619.00 | 2021-06-11 | 491089203 | 18188489 | 7 | cormorant-ecor1-logos-perceptive-racapital-orbimed-tang |
| 16 | KYMR | 2025-03-31 | Kymera Therapeutics, Inc. | 25.97 | 1,686,598,272.00 | -40.57% | 42,816,370.00 | 2020-08-21 | 482197270 | 17617730 | 3 | avoro-baker-bvf |
| 17 | SMMT | 2025-03-31 | Summit Therapeutics Inc. | 24.61 | 18,154,305,536.00 | 11.36% | 111,183,085.00 | 2015-03-05 | 471155646 | 24424865 | 1 | baker |
| 18 | ACLX | 2025-03-31 | Arcellx, Inc. | 59.15 | 3,249,937,664.00 | -12.19% | 32,601,579.00 | 2022-02-04 | 460053128 | 7013005 | 3 | cormorant-perceptive-racapital |
| 19 | VRNA | 2025-03-31 | Verona Pharma plc | 65.46 | 8,622,652,416.00 | 21.92% | 493,924,450.00 | 2017-04-28 | 430918249 | 6787183 | 2 | baker-perceptive |
| 20 | BPMC | 2025-03-31 | Blueprint Medicines Corporation | 84.69 | 5,412,199,424.00 | -24.36% | 63,174,287.00 | 2015-04-30 | 369651217 | 4176378 | 2 | avoro-casdin |
| 21 | SRPT | 2025-03-31 | Sarepta Therapeutics, Inc. | 53.79 | 5,219,356,672.00 | -53.94% | 92,551,132.00 | 1997-06-04 | 368096848 | 5767735 | 4 | avoro-casdin-deeptrack-ecor1 |
| 22 | FOLD | 2025-03-31 | Amicus Therapeutics, Inc. | 6.83 | 2,098,449,152.00 | -28.18% | 250,897,044.00 | 2007-05-31 | 361079404 | 44249927 | 3 | avoro-perceptive-orbimed |
| 23 | PTGX | 2025-03-31 | Protagonist Therapeutics, Inc. | 46.28 | 2,840,865,280.00 | 21.47% | 46,016,118.00 | 2016-08-11 | 327459391 | 6771286 | 4 | bvf-deeptrack-perceptive-opaleye |
| 24 | AXSM | 2025-03-31 | Axsome Therapeutics, Inc. | 104.46 | 5,094,033,408.00 | 8.61% | 36,674,021.00 | 2015-11-19 | 312804925 | 2682028 | 4 | bvf-cormorant-perceptive-orbimed |
| 25 | WGS | 2025-03-31 | GeneDx Holdings Corp. | 96.63 | 2,712,239,872.00 | 13.67% | 18,444,224.00 | 2020-11-04 | 310611980 | 3507164 | 1 | casdin |
| 26 | SLNO | 2025-03-31 | Soleno Therapeutics, Inc. | 69.98 | 3,209,093,888.00 | 42.32% | 31,320,071.00 | 2014-11-13 | 309492963 | 4331602 | 4 | avoro-logos-perceptive-tang |
| 27 | IMVT | 2025-03-31 | Immunovant, Inc. | 15.15 | 2,573,393,920.00 | -35.78% | 62,221,667.00 | 2019-06-21 | 308935126 | 18076953 | 4 | baker-deeptrack-logos-perceptive |
| 28 | DVAX | 2025-03-31 | Dynavax Technologies Corporatio | 10.31 | 1,279,172,096.00 | -18.69% | 99,188,424.00 | 2004-02-19 | 305333073 | 23541486 | 2 | deeptrack-tang |
| 29 | XENE | 2025-03-31 | Xenon Pharmaceuticals Inc. | 31.40 | 2,403,443,968.00 | -17.91% | 70,775,310.00 | 2014-11-05 | 302361825 | 9012275 | 6 | avoro-baker-deeptrack-logos-perceptive-orbimed |
| 30 | BSX | 2025-03-31 | Boston Scientific Corporation | 93.67 | 138,544,480,256.00 | -0.99% | 1,471,454,074.00 | 1992-05-19 | 296910016 | 2943200 | 2 | perceptive-orbimed |
| 31 | ZYME | 2025-03-31 | Zymeworks Inc. | 10.63 | 739,602,432.00 | -23.85% | 38,672,223.00 | 2017-04-28 | 294274127 | 24708155 | 5 | bvf-ecor1-perceptive-opaleye-tang |
| 32 | IONS | 2025-03-31 | Ionis Pharmaceuticals, Inc. | 28.40 | 4,514,605,568.00 | -13.10% | 157,589,727.00 | 1991-05-17 | 287388649 | 9525643 | 5 | baker-bvf-deeptrack-orbimed-tang |
| 33 | LLY | 2025-03-31 | Eli Lilly and Company | 839.96 | 754,274,861,056.00 | 13.15% | 895,933,556.00 | 1972-06-01 | 278827216 | 337600 | 1 | orbimed |
| 34 | ETNB | 2025-03-31 | 89bio, Inc. | 6.06 | 884,663,040.00 | -7.90% | 107,537,788.00 | 2019-11-11 | 276667236 | 38056016 | 4 | avoro-deeptrack-logos-racapital |
| 35 | NAMS | 2025-03-31 | NewAmsterdam Pharma Company N.V | 15.12 | 1,660,448,128.00 | -38.49% | 53,941,411.00 | 2021-02-09 | 266580872 | 13023003 | 3 | bvf-cormorant-racapital |
| 36 | SPRY | 2025-03-31 | ARS Pharmaceuticals, Inc. | 14.05 | 1,378,583,168.00 | 24.78% | 47,452,700.00 | 2020-12-04 | 261028547 | 20749487 | 3 | cormorant-racapital-orbimed |
| 37 | AKRO | 2025-03-31 | Akero Therapeutics, Inc. | 37.63 | 2,996,104,192.00 | 46.99% | 66,438,220.00 | 2019-06-20 | 257932205 | 6371843 | 6 | baker-deeptrack-ecor1-logos-perceptive-orbimed |
| 38 | TARS | 2025-03-31 | Tarsus Pharmaceuticals, Inc. | 46.43 | 1,931,836,288.00 | -1.25% | 29,909,637.00 | 2020-10-16 | 256480444 | 4992806 | 4 | cormorant-deeptrack-orbimed-tang |
| 39 | GH | 2025-03-31 | Guardant Health, Inc. | 44.97 | 5,550,242,304.00 | -0.35% | 111,589,027.00 | 2018-10-04 | 242552515 | 5693721 | 2 | casdin-deeptrack |
New Positions (Not previously in any of the funds) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | AMGN | 2025-03-31 | Amgen Inc. | 277.29 | 149,085,257,728.00 | 0.90% | 535,673,909.00 | 1983-06-17 | 48986564 | 157235 | 2 | deeptrack-orbimed | New |
| 1 | SNWV | 2025-03-31 | SANUWAVE Health, Inc. | 29.92 | 255,770,224.00 | 10.81% | 5,600,874.00 | 2025-03-03 | 34379711 | 972002 | 1 | opaleye | New |
| 2 | TEVA | 2025-03-31 | Teva Pharmaceutical Industries | 13.65 | 15,656,003,584.00 | -37.44% | 1,128,838,460.00 | 1982-02-16 | 26129000 | 1700000 | 1 | logos | New |
| 3 | GKOS | 2025-03-31 | Glaukos Corporation | 90.07 | 5,095,025,664.00 | -40.69% | 54,680,371.00 | 2015-06-25 | 18724996 | 190256 | 1 | racapital | New |
| 4 | RGEN | 2025-03-31 | Repligen Corporation | 130.00 | 7,303,283,200.00 | -22.58% | 52,524,167.00 | 1986-04-29 | 16515879 | 129801 | 1 | perceptive | New |
| 5 | SAGE | 2025-03-31 | Sage Therapeutics, Inc. | 7.43 | 456,803,072.00 | 7.06% | 49,262,838.00 | 2014-07-18 | 16208818 | 2038845 | 1 | deeptrack | New |
| 6 | DXCM | 2025-03-31 | DexCom, Inc. | 66.14 | 25,933,957,120.00 | -17.16% | 387,927,198.00 | 2005-04-14 | 12155620 | 178000 | 1 | perceptive | New |
| 7 | KMTS | 2025-03-31 | Kestra Medical Technologies, Lt | 24.28 | 1,245,957,376.00 | 11.17% | 23,036,693.00 | 2025-03-06 | 11214000 | 450000 | 2 | perceptive-orbimed | New |
| 8 | AQST | 2025-03-31 | Aquestive Therapeutics, Inc. | 2.51 | 248,167,216.00 | -21.81% | 94,253,087.00 | 2018-07-25 | 10808903 | 3727208 | 1 | perceptive | New |
| 9 | OM | 2025-03-31 | Outset Medical, Inc. | 10.16 | 179,827,936.00 | -16.17% | 2,773,914.00 | 2020-09-15 | 9216662 | 833333 | 1 | perceptive | New |
| 10 | RCUS | 2025-03-31 | Arcus Biosciences, Inc. | 7.88 | 834,027,072.00 | -44.27% | 65,841,832.00 | 2018-03-15 | 8920457 | 1136364 | 1 | racapital | New |
| 11 | GEHC | 2025-03-31 | GE HealthCare Technologies Inc. | 62.81 | 28,757,118,976.00 | -26.42% | 456,100,188.00 | 2022-12-15 | 8071000 | 100000 | 1 | casdin | New |
| 12 | ADPT | 2025-03-31 | Adaptive Biotechnologies Corpor | 7.33 | 1,089,106,048.00 | -1.61% | 96,477,395.00 | 2019-06-27 | 6917122 | 930972 | 1 | perceptive | New |
| 13 | ACHC | 2025-03-31 | Acadia Healthcare Company, Inc. | 26.15 | 2,409,142,016.00 | -42.41% | 90,430,406.00 | 1994-03-04 | 6579440 | 217000 | 1 | racapital | New |
| 14 | ANIK | 2025-03-31 | Anika Therapeutics Inc. | 14.02 | 198,747,520.00 | -15.03% | 10,199,202.00 | 1993-05-03 | 5936850 | 395000 | 1 | opaleye | New |
| 15 | HUMA | 2025-03-31 | Humacyte, Inc. | 1.53 | 237,332,080.00 | -65.15% | 121,986,988.00 | 2020-12-01 | 5647567 | 3312356 | 1 | racapital | New |
| 16 | RCEL | 2025-03-31 | Avita Medical, Inc. | 8.62 | 227,201,648.00 | -2.27% | 25,848,578.00 | 2012-05-14 | 3581600 | 440000 | 1 | opaleye | New |
| 17 | STRO | 2025-03-31 | Sutro Biopharma, Inc. | 0.53 | 43,948,524.00 | -73.64% | 70,805,238.00 | 2018-09-27 | 3015295 | 4634637 | 2 | racapital-tang | New |
| 18 | BLUE | 2025-03-31 | bluebird bio, Inc. | 4.14 | 40,530,888.00 | -49.14% | 9,723,595.00 | 2013-06-19 | 1952000 | 400000 | 1 | tang | New |
| 19 | OPTN | 2025-03-31 | OptiNose, Inc. | 9.17 | 92,868,256.00 | 32.51% | 6,396,590.00 | 2017-10-13 | 1770168 | 193039 | 1 | opaleye | New |
| 20 | CAPR | 2025-03-31 | Capricor Therapeutics, Inc. | 11.25 | 513,865,120.00 | -19.99% | 40,145,727.00 | 2007-02-13 | 750659 | 79100 | 1 | tang | New |
| 21 | SGMO | 2025-03-31 | Sangamo Therapeutics, Inc. | 0.71 | 158,555,376.00 | -37.56% | 218,822,617.00 | 2000-04-06 | 691869 | 1055000 | 1 | opaleye | New |
| 22 | DHAI | 2025-03-31 | DIH Holding US, Inc. | 0.14 | 6,433,003.00 | -90.08% | 17,851,910.00 | 2024-02-14 | 442940 | 1915000 | 1 | orbimed | New |
| 23 | SAVA | 2025-03-31 | Cassava Sciences, Inc. | 1.44 | 69,563,376.00 | -45.04% | 43,475,174.00 | 2000-07-14 | 300000 | 200000 | 1 | tang | New |
| 24 | QNCX | 2025-03-31 | Quince Therapeutics, Inc. | 1.00 | 44,001,600.00 | -42.20% | 32,660,220.00 | 2019-05-09 | 245229 | 184383 | 1 | tang | New |
| 25 | MGX | 2025-03-31 | Metagenomi, Inc. | 1.48 | 55,327,580.00 | -49.14% | 23,310,838.00 | 2024-02-09 | 183570 | 134978 | 1 | tang | New |
------------------------------------------------------------ ------------------------------------------------------------ New Positions (Not previously in any of the funds) Sorted by Number of Funds initiating the new position
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | AMGN | 2025-03-31 | Amgen Inc. | 277.29 | 149,085,257,728.00 | 0.90% | 535,673,909.00 | 1983-06-17 | 48986564 | 157235 | 2 | deeptrack-orbimed |
| 1 | KMTS | 2025-03-31 | Kestra Medical Technologies, Lt | 24.28 | 1,245,957,376.00 | 11.17% | 23,036,693.00 | 2025-03-06 | 11214000 | 450000 | 2 | perceptive-orbimed |
| 2 | STRO | 2025-03-31 | Sutro Biopharma, Inc. | 0.53 | 43,948,524.00 | -73.64% | 70,805,238.00 | 2018-09-27 | 3015295 | 4634637 | 2 | racapital-tang |
| 3 | ANIK | 2025-03-31 | Anika Therapeutics Inc. | 14.02 | 198,747,520.00 | -15.03% | 10,199,202.00 | 1993-05-03 | 5936850 | 395000 | 1 | opaleye |
| 4 | QNCX | 2025-03-31 | Quince Therapeutics, Inc. | 1.00 | 44,001,600.00 | -42.20% | 32,660,220.00 | 2019-05-09 | 245229 | 184383 | 1 | tang |
| 5 | SAVA | 2025-03-31 | Cassava Sciences, Inc. | 1.44 | 69,563,376.00 | -45.04% | 43,475,174.00 | 2000-07-14 | 300000 | 200000 | 1 | tang |
| 6 | DHAI | 2025-03-31 | DIH Holding US, Inc. | 0.14 | 6,433,003.00 | -90.08% | 17,851,910.00 | 2024-02-14 | 442940 | 1915000 | 1 | orbimed |
| 7 | SGMO | 2025-03-31 | Sangamo Therapeutics, Inc. | 0.71 | 158,555,376.00 | -37.56% | 218,822,617.00 | 2000-04-06 | 691869 | 1055000 | 1 | opaleye |
| 8 | CAPR | 2025-03-31 | Capricor Therapeutics, Inc. | 11.25 | 513,865,120.00 | -19.99% | 40,145,727.00 | 2007-02-13 | 750659 | 79100 | 1 | tang |
| 9 | OPTN | 2025-03-31 | OptiNose, Inc. | 9.17 | 92,868,256.00 | 32.51% | 6,396,590.00 | 2017-10-13 | 1770168 | 193039 | 1 | opaleye |
| 10 | BLUE | 2025-03-31 | bluebird bio, Inc. | 4.14 | 40,530,888.00 | -49.14% | 9,723,595.00 | 2013-06-19 | 1952000 | 400000 | 1 | tang |
| 11 | RCEL | 2025-03-31 | Avita Medical, Inc. | 8.62 | 227,201,648.00 | -2.27% | 25,848,578.00 | 2012-05-14 | 3581600 | 440000 | 1 | opaleye |
| 12 | HUMA | 2025-03-31 | Humacyte, Inc. | 1.53 | 237,332,080.00 | -65.15% | 121,986,988.00 | 2020-12-01 | 5647567 | 3312356 | 1 | racapital |
| 13 | ACHC | 2025-03-31 | Acadia Healthcare Company, Inc. | 26.15 | 2,409,142,016.00 | -42.41% | 90,430,406.00 | 1994-03-04 | 6579440 | 217000 | 1 | racapital |
| 14 | SNWV | 2025-03-31 | SANUWAVE Health, Inc. | 29.92 | 255,770,224.00 | 10.81% | 5,600,874.00 | 2025-03-03 | 34379711 | 972002 | 1 | opaleye |
| 15 | ADPT | 2025-03-31 | Adaptive Biotechnologies Corpor | 7.33 | 1,089,106,048.00 | -1.61% | 96,477,395.00 | 2019-06-27 | 6917122 | 930972 | 1 | perceptive |
| 16 | GEHC | 2025-03-31 | GE HealthCare Technologies Inc. | 62.81 | 28,757,118,976.00 | -26.42% | 456,100,188.00 | 2022-12-15 | 8071000 | 100000 | 1 | casdin |
| 17 | RCUS | 2025-03-31 | Arcus Biosciences, Inc. | 7.88 | 834,027,072.00 | -44.27% | 65,841,832.00 | 2018-03-15 | 8920457 | 1136364 | 1 | racapital |
| 18 | OM | 2025-03-31 | Outset Medical, Inc. | 10.16 | 179,827,936.00 | -16.17% | 2,773,914.00 | 2020-09-15 | 9216662 | 833333 | 1 | perceptive |
| 19 | AQST | 2025-03-31 | Aquestive Therapeutics, Inc. | 2.51 | 248,167,216.00 | -21.81% | 94,253,087.00 | 2018-07-25 | 10808903 | 3727208 | 1 | perceptive |
| 20 | DXCM | 2025-03-31 | DexCom, Inc. | 66.14 | 25,933,957,120.00 | -17.16% | 387,927,198.00 | 2005-04-14 | 12155620 | 178000 | 1 | perceptive |
| 21 | SAGE | 2025-03-31 | Sage Therapeutics, Inc. | 7.43 | 456,803,072.00 | 7.06% | 49,262,838.00 | 2014-07-18 | 16208818 | 2038845 | 1 | deeptrack |
| 22 | RGEN | 2025-03-31 | Repligen Corporation | 130.00 | 7,303,283,200.00 | -22.58% | 52,524,167.00 | 1986-04-29 | 16515879 | 129801 | 1 | perceptive |
| 23 | GKOS | 2025-03-31 | Glaukos Corporation | 90.07 | 5,095,025,664.00 | -40.69% | 54,680,371.00 | 2015-06-25 | 18724996 | 190256 | 1 | racapital |
| 24 | TEVA | 2025-03-31 | Teva Pharmaceutical Industries | 13.65 | 15,656,003,584.00 | -37.44% | 1,128,838,460.00 | 1982-02-16 | 26129000 | 1700000 | 1 | logos |
| 25 | MGX | 2025-03-31 | Metagenomi, Inc. | 1.48 | 55,327,580.00 | -49.14% | 23,310,838.00 | 2024-02-09 | 183570 | 134978 | 1 | tang |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ASND | 2025-03-31 | Ascendis Pharma A/S | 165.05 | 9,923,581,952.00 | 25.93% | 59,372,631.00 | 2015-01-28 | 2415751447 | 15499496 | 2 | avoro-racapital | 1.86% | Increased |
| 1 | INCY | 2025-03-31 | Incyte Corporation | 58.21 | 11,265,032,192.00 | -20.77% | 161,370,279.00 | 1993-11-04 | 1861304154 | 30739953 | 1 | baker | 0.00% | Increased |
| 2 | MDGL | 2025-03-31 | Madrigal Pharmaceuticals, Inc. | 301.66 | 6,660,712,960.00 | -1.77% | 11,356,312.00 | 2007-02-06 | 1364108484 | 4118312 | 4 | avoro-baker-ecor1-perceptive | 0.97% | Increased |
| 3 | MLTX | 2025-03-31 | MoonLake Immunotherapeutics | 34.90 | 2,208,566,272.00 | -22.88% | 28,073,483.00 | 2020-10-20 | 1225451453 | 31365535 | 4 | avoro-bvf-cormorant-logos | 0.06% | Increased |
| 4 | EWTX | 2025-03-31 | Edgewise Therapeutics, Inc. | 11.42 | 1,200,710,272.00 | -54.92% | 54,187,991.00 | 2021-03-26 | 942283584 | 42831072 | 8 | baker-cormorant-deeptrack-perceptive-racapital-orbimed-opaleye-tang | 12.51% | Increased |
| 5 | APLS | 2025-03-31 | Apellis Pharmaceuticals, Inc. | 18.20 | 2,284,391,168.00 | -39.60% | 84,226,131.00 | 2017-11-09 | 668135717 | 30550330 | 4 | avoro-deeptrack-ecor1-orbimed | 5.75% | Increased |
| 6 | RVMD | 2025-03-31 | Revolution Medicines, Inc. | 36.76 | 6,834,161,152.00 | -8.47% | 168,212,518.00 | 2020-02-13 | 647699339 | 18317289 | 5 | baker-bvf-casdin-logos-tang | 5.47% | Increased |
| 7 | PCVX | 2025-03-31 | Vaxcyte, Inc. | 30.65 | 3,946,555,136.00 | -65.24% | 119,134,116.00 | 2020-06-12 | 595158054 | 15761601 | 7 | avoro-baker-cormorant-deeptrack-perceptive-racapital-tang | 23.80% | Increased |
| 8 | RNA | 2025-03-31 | Avidity Biosciences, Inc. | 26.66 | 3,204,851,968.00 | -13.55% | 92,698,110.00 | 2020-06-12 | 563562483 | 19090870 | 7 | avoro-casdin-cormorant-ecor1-logos-racapital-orbimed | 2.83% | Increased |
| 9 | INSM | 2025-03-31 | Insmed Incorporated | 72.65 | 13,209,223,168.00 | -5.34% | 166,410,802.00 | 2000-06-01 | 533903054 | 6998336 | 7 | baker-cormorant-deeptrack-perceptive-racapital-orbimed-tang | 5.31% | Increased |
| 10 | JANX | 2025-03-31 | Janux Therapeutics, Inc. | 28.80 | 1,702,226,816.00 | -36.09% | 37,290,619.00 | 2021-06-11 | 491089203 | 18188489 | 7 | cormorant-ecor1-logos-perceptive-racapital-orbimed-tang | 8.19% | Increased |
| 11 | KYMR | 2025-03-31 | Kymera Therapeutics, Inc. | 25.97 | 1,686,598,272.00 | -40.57% | 42,816,370.00 | 2020-08-21 | 482197270 | 17617730 | 3 | avoro-baker-bvf | 5.76% | Increased |
| 12 | BPMC | 2025-03-31 | Blueprint Medicines Corporation | 84.69 | 5,412,199,424.00 | -24.36% | 63,174,287.00 | 2015-04-30 | 369651217 | 4176378 | 2 | avoro-casdin | 144.04% | Increased |
| 13 | SRPT | 2025-03-31 | Sarepta Therapeutics, Inc. | 53.79 | 5,219,356,672.00 | -53.94% | 92,551,132.00 | 1997-06-04 | 368096848 | 5767735 | 4 | avoro-casdin-deeptrack-ecor1 | 7.56% | Increased |
| 14 | PTGX | 2025-03-31 | Protagonist Therapeutics, Inc. | 46.28 | 2,840,865,280.00 | 21.47% | 46,016,118.00 | 2016-08-11 | 327459391 | 6771286 | 4 | bvf-deeptrack-perceptive-opaleye | 58.33% | Increased |
| 15 | IMVT | 2025-03-31 | Immunovant, Inc. | 15.15 | 2,573,393,920.00 | -35.78% | 62,221,667.00 | 2019-06-21 | 308935126 | 18076953 | 4 | baker-deeptrack-logos-perceptive | 76.78% | Increased |
| 16 | DVAX | 2025-03-31 | Dynavax Technologies Corporatio | 10.31 | 1,279,172,096.00 | -18.69% | 99,188,424.00 | 2004-02-19 | 305333073 | 23541486 | 2 | deeptrack-tang | 19.86% | Increased |
| 17 | XENE | 2025-03-31 | Xenon Pharmaceuticals Inc. | 31.40 | 2,403,443,968.00 | -17.91% | 70,775,310.00 | 2014-11-05 | 302361825 | 9012275 | 6 | avoro-baker-deeptrack-logos-perceptive-orbimed | 11.23% | Increased |
| 18 | ZYME | 2025-03-31 | Zymeworks Inc. | 10.63 | 739,602,432.00 | -23.85% | 38,672,223.00 | 2017-04-28 | 294274127 | 24708155 | 5 | bvf-ecor1-perceptive-opaleye-tang | 9.49% | Increased |
| 19 | IONS | 2025-03-31 | Ionis Pharmaceuticals, Inc. | 28.40 | 4,514,605,568.00 | -13.10% | 157,589,727.00 | 1991-05-17 | 287388649 | 9525643 | 5 | baker-bvf-deeptrack-orbimed-tang | 81.12% | Increased |
| 20 | ETNB | 2025-03-31 | 89bio, Inc. | 6.06 | 884,663,040.00 | -7.90% | 107,537,788.00 | 2019-11-11 | 276667236 | 38056016 | 4 | avoro-deeptrack-logos-racapital | 30.83% | Increased |
| 21 | NAMS | 2025-03-31 | NewAmsterdam Pharma Company N.V | 15.12 | 1,660,448,128.00 | -38.49% | 53,941,411.00 | 2021-02-09 | 266580872 | 13023003 | 3 | bvf-cormorant-racapital | 4.86% | Increased |
| 22 | SPRY | 2025-03-31 | ARS Pharmaceuticals, Inc. | 14.05 | 1,378,583,168.00 | 24.78% | 47,452,700.00 | 2020-12-04 | 261028547 | 20749487 | 3 | cormorant-racapital-orbimed | 5.60% | Increased |
| 23 | AKRO | 2025-03-31 | Akero Therapeutics, Inc. | 37.63 | 2,996,104,192.00 | 46.99% | 66,438,220.00 | 2019-06-20 | 257932205 | 6371843 | 6 | baker-deeptrack-ecor1-logos-perceptive-orbimed | 37.36% | Increased |
| 24 | TARS | 2025-03-31 | Tarsus Pharmaceuticals, Inc. | 46.43 | 1,931,836,288.00 | -1.25% | 29,909,637.00 | 2020-10-16 | 256480444 | 4992806 | 4 | cormorant-deeptrack-orbimed-tang | 69.74% | Increased |
| 25 | GHRS | 2025-03-31 | GH Research PLC | 9.00 | 558,252,928.00 | 7.78% | 17,280,108.00 | 2021-06-25 | 218193716 | 19781842 | 4 | bvf-cormorant-deeptrack-racapital | 11.89% | Increased |
| 26 | MRUS | 2025-03-31 | Merus N.V. | 43.05 | 2,974,691,328.00 | 8.34% | 55,639,246.00 | 2016-05-19 | 200095229 | 4753985 | 5 | avoro-baker-cormorant-perceptive-tang | 6.47% | Increased |
| 27 | ELVN | 2025-03-31 | Enliven Therapeutics, Inc. | 16.51 | 809,062,656.00 | -25.19% | 26,934,302.00 | 2020-03-12 | 185254865 | 9413357 | 5 | baker-cormorant-logos-racapital-orbimed | 1.07% | Increased |
| 28 | IRON | 2025-03-31 | Disc Medicine, Inc. | 38.73 | 1,338,857,344.00 | -34.07% | 26,301,510.00 | 2020-08-12 | 183594434 | 3698518 | 6 | baker-logos-perceptive-racapital-orbimed-opaleye | 79.31% | Increased |
| 29 | ANAB | 2025-03-31 | AnaptysBio, Inc. | 20.55 | 630,202,688.00 | 21.74% | 18,032,374.00 | 2017-01-26 | 179880185 | 9676180 | 3 | ecor1-opaleye-tang | 5.13% | Increased |
| 30 | DYN | 2025-03-31 | Dyne Therapeutics, Inc. | 7.04 | 796,371,840.00 | -53.96% | 97,275,317.00 | 2020-09-17 | 170649690 | 16314502 | 7 | baker-casdin-deeptrack-logos-perceptive-racapital-orbimed | 37.92% | Increased |
| 31 | GERN | 2025-03-31 | Geron Corporation | 1.27 | 808,879,552.00 | -57.09% | 601,237,820.00 | 1996-07-31 | 169423431 | 106555617 | 3 | deeptrack-logos-racapital | 179.02% | Increased |
| 32 | IMCR | 2025-03-31 | Immunocore Holdings plc | 26.59 | 1,312,099,456.00 | -11.46% | 37,260,699.00 | 2021-02-05 | 167628557 | 5649766 | 3 | baker-deeptrack-tang | 57.36% | Increased |
| 33 | BBIO | 2025-03-31 | BridgeBio Pharma, Inc. | 33.87 | 6,441,700,864.00 | -6.13% | 139,058,316.00 | 2019-06-27 | 165936000 | 4800000 | 2 | cormorant-deeptrack | 98.42% | Increased |
| 34 | GPCR | 2025-03-31 | Structure Therapeutics Inc. | 15.90 | 911,750,528.00 | -36.80% | 148,959,516.00 | 2023-02-03 | 164919779 | 9527428 | 7 | baker-bvf-casdin-deeptrack-logos-racapital-orbimed | 12.06% | Increased |
| 35 | GLPG | 2025-03-31 | Galapagos NV | 24.66 | 1,640,030,592.00 | 3.48% | 44,538,512.00 | 2012-02-27 | 158564801 | 6312293 | 4 | bvf-deeptrack-ecor1-tang | 35.27% | Increased |
| 36 | TYRA | 2025-03-31 | Tyra Biosciences, Inc. | 7.96 | 422,596,416.00 | -47.28% | 21,075,120.00 | 2021-09-15 | 152007774 | 16344922 | 4 | baker-bvf-racapital-orbimed | 1.76% | Increased |
| 37 | REPL | 2025-03-31 | Replimune Group, Inc. | 8.00 | 615,733,312.00 | -32.53% | 53,003,113.00 | 2018-07-20 | 144257851 | 14795677 | 3 | baker-ecor1-tang | 1.37% | Increased |
| 38 | RARE | 2025-03-31 | Ultragenyx Pharmaceutical Inc. | 35.69 | 3,351,280,128.00 | -13.54% | 89,184,961.00 | 2014-01-31 | 136008888 | 3756114 | 3 | avoro-baker-deeptrack | 22.76% | Increased |
| 39 | SYK | 2025-03-31 | Stryker Corporation | 350.28 | 133,698,019,328.00 | -2.96% | 343,306,737.00 | 1980-03-17 | 133712200 | 359200 | 1 | orbimed | 4.30% | Increased |
| 40 | NRIX | 2025-03-31 | Nurix Therapeutics, Inc. | 10.24 | 780,652,544.00 | -47.76% | 59,122,228.00 | 2020-07-24 | 132200771 | 11128011 | 5 | baker-deeptrack-perceptive-racapital-opaleye | 24.69% | Increased |
| 41 | VRDN | 2025-03-31 | Viridian Therapeutics, Inc. | 12.02 | 979,449,728.00 | -32.36% | 76,929,941.00 | 2014-06-18 | 119069326 | 8833036 | 3 | deeptrack-perceptive-tang | 3.89% | Increased |
| 42 | XNCR | 2025-03-31 | Xencor, Inc. | 8.54 | 601,744,640.00 | -57.85% | 63,604,579.00 | 2013-12-03 | 113632838 | 10679778 | 5 | baker-bvf-deeptrack-ecor1-racapital | 4.92% | Increased |
| 43 | EW | 2025-03-31 | Edwards Lifesciences Corporatio | 69.40 | 40,651,399,168.00 | -2.38% | 581,838,751.00 | 2000-03-27 | 111039360 | 1532000 | 1 | orbimed | 18.73% | Increased |
| 44 | KNSA | 2025-03-31 | Kiniksa Pharmaceuticals, Ltd. | 20.21 | 1,468,139,264.00 | 8.02% | 23,218,552.00 | 2018-05-25 | 111036741 | 4999403 | 3 | baker-opaleye-tang | 45.04% | Increased |
| 45 | UNH | 2025-03-31 | UnitedHealth Group Incorporated | 599.47 | 548,342,366,208.00 | 10.78% | 912,224,315.00 | 1984-10-17 | 107233042 | 204741 | 2 | orbimed-tang | 53.70% | Increased |
| 46 | CELC | 2025-03-31 | Celcuity Inc. | 10.24 | 387,475,456.00 | -8.65% | 20,768,907.00 | 2017-09-20 | 101969602 | 10086014 | 3 | baker-bvf-perceptive | 18.56% | Increased |
| 47 | DNTH | 2025-03-31 | Dianthus Therapeutics, Inc. | 17.61 | 565,737,088.00 | -23.57% | 14,121,907.00 | 2018-06-21 | 99572764 | 5489127 | 3 | deeptrack-racapital-tang | 157.57% | Increased |
| 48 | PFE | 2025-03-31 | Pfizer, Inc. | 22.14 | 125,565,902,848.00 | -16.89% | 5,657,705,935.00 | 1972-06-01 | 99256787 | 3917000 | 2 | orbimed-tang | 9028.83% | Increased |
| 49 | IDYA | 2025-03-31 | IDEAYA Biosciences, Inc. | 17.08 | 1,495,138,816.00 | -26.22% | 86,629,628.00 | 2019-05-23 | 96795563 | 5909375 | 3 | baker-logos-racapital | 9.24% | Increased |
| 50 | KURA | 2025-03-31 | Kura Oncology, Inc. | 5.90 | 476,587,840.00 | -20.16% | 59,769,977.00 | 2015-09-16 | 95693644 | 14499037 | 4 | bvf-ecor1-racapital-tang | 12.17% | Increased |
| 51 | SEPN | 2025-03-31 | Septerna, Inc. | 5.72 | 254,211,088.00 | -66.35% | 19,629,806.00 | 2024-10-25 | 88760012 | 15329881 | 6 | avoro-bvf-casdin-deeptrack-logos-racapital | 5.96% | Increased |
| 52 | CGON | 2025-03-31 | CG Oncology, Inc. | 19.28 | 1,469,461,760.00 | -32.78% | 60,853,824.00 | 2024-01-25 | 83534949 | 3410982 | 3 | cormorant-orbimed-opaleye | 2.57% | Increased |
| 53 | LAB | 2025-03-31 | Standard BioTools Inc. | 1.15 | 435,833,888.00 | -44.17% | 48,240,936.00 | 2011-02-10 | 82602062 | 76483391 | 2 | casdin-tang | 6.73% | Increased |
| 54 | AUPH | 2025-03-31 | Aurinia Pharmaceuticals Inc | 7.75 | 1,064,377,344.00 | 0.26% | 133,424,854.00 | 2014-09-03 | 80637180 | 10029500 | 1 | tang | 18.98% | Increased |
| 55 | MBX | 2025-03-31 | MBX Biosciences, Inc. | 7.41 | 247,674,800.00 | -40.53% | 13,610,404.00 | 2024-09-13 | 79279126 | 10742429 | 6 | cormorant-deeptrack-ecor1-racapital-orbimed-opaleye | 4.28% | Increased |
| 56 | ITGR | 2025-03-31 | Integer Holdings Corporation | 116.50 | 4,064,673,280.00 | -13.80% | 32,987,365.00 | 2000-09-29 | 78181625 | 662500 | 1 | orbimed | 15.22% | Increased |
| 57 | VRTX | 2025-03-31 | Vertex Pharmaceuticals Incorpor | 493.84 | 126,956,879,872.00 | 11.26% | 256,181,277.00 | 1991-07-24 | 77522718 | 159900 | 1 | orbimed | 5.89% | Increased |
| 58 | NTRA | 2025-03-31 | Natera, Inc. | 148.08 | 20,018,343,936.00 | -11.57% | 130,699,355.00 | 2015-07-01 | 77351270 | 547000 | 1 | orbimed | 1.67% | Increased |
| 59 | TRML | 2025-03-31 | Tourmaline Bio, Inc. | 13.10 | 336,478,752.00 | -32.72% | 15,577,956.00 | 2021-05-07 | 75501299 | 4963925 | 2 | avoro-racapital | 4.26% | Increased |
| 60 | SYRE | 2025-03-31 | Spyre Therapeutics, Inc. | 12.22 | 736,340,544.00 | -43.29% | 46,620,133.00 | 2016-04-07 | 73935201 | 4582287 | 3 | deeptrack-perceptive-tang | 39.12% | Increased |
| 61 | GLUE | 2025-03-31 | Monte Rosa Therapeutics, Inc. | 4.22 | 259,571,344.00 | -25.44% | 33,917,745.00 | 2021-06-24 | 71028141 | 15307789 | 4 | avoro-baker-bvf-casdin | 26.39% | Increased |
| 62 | ANIP | 2025-03-31 | ANI Pharmaceuticals, Inc. | 69.21 | 1,493,150,336.00 | 18.61% | 16,794,626.00 | 2000-05-05 | 68121625 | 1017500 | 2 | deeptrack-tang | 5.27% | Increased |
| 63 | CGEM | 2025-03-31 | Cullinan Therapeutics, Inc. | 7.71 | 451,133,696.00 | -30.16% | 38,980,660.00 | 2021-01-08 | 67189624 | 8875776 | 4 | bvf-perceptive-orbimed-tang | 3.03% | Increased |
| 64 | SLDB | 2025-03-31 | Solid Biosciences Inc. | 2.55 | 197,607,152.00 | -21.78% | 39,269,557.00 | 2018-01-26 | 66069205 | 17856542 | 5 | casdin-ecor1-logos-perceptive-racapital | 58.91% | Increased |
| 65 | QURE | 2025-03-31 | uniQure N.V. | 13.00 | 702,999,680.00 | -12.81% | 44,295,995.00 | 2014-02-05 | 65338093 | 6163971 | 2 | avoro-ecor1 | 10.56% | Increased |
| 66 | CMPX | 2025-03-31 | Compass Therapeutics, Inc. | 1.70 | 234,388,000.00 | -13.08% | 83,586,239.00 | 2021-04-05 | 64529662 | 33962980 | 3 | baker-orbimed-tang | 13.89% | Increased |
| 67 | TMO | 2025-03-31 | Thermo Fisher Scientific Inc | 438.15 | 165,398,118,400.00 | -21.13% | 376,446,298.00 | 1980-03-17 | 64190400 | 129000 | 1 | orbimed | 52.84% | Increased |
| 68 | ETON | 2025-03-31 | Eton Pharmaceuticals, Inc. | 14.34 | 384,562,944.00 | -6.09% | 20,737,195.00 | 2018-11-13 | 62191827 | 4791358 | 2 | ecor1-opaleye | 2.34% | Increased |
| 69 | KALV | 2025-03-31 | KalVista Pharmaceuticals, Inc. | 12.00 | 596,587,200.00 | 37.14% | 29,072,212.00 | 2015-04-09 | 57028349 | 4941798 | 1 | tang | 0.98% | Increased |
| 70 | ITOS | 2025-03-31 | iTeos Therapeutics, Inc. | 6.51 | 248,644,896.00 | -19.23% | 29,147,629.00 | 2020-07-24 | 56197144 | 9413257 | 3 | bvf-racapital-tang | 102.92% | Increased |
| 71 | IMNM | 2025-03-31 | Immunome, Inc. | 7.10 | 617,350,016.00 | -29.28% | 69,554,437.00 | 2020-10-02 | 51345963 | 7629415 | 2 | ecor1-opaleye | 28.89% | Increased |
| 72 | LQDA | 2025-03-31 | Liquidia Corporation | 13.72 | 1,170,295,424.00 | 0.73% | 66,205,312.00 | 2018-07-26 | 51035000 | 3460000 | 2 | opaleye-tang | 23.65% | Increased |
| 73 | PTCT | 2025-03-31 | PTC Therapeutics, Inc. | 47.39 | 3,737,620,736.00 | 4.73% | 63,207,489.00 | 2013-06-20 | 50960000 | 1000000 | 1 | tang | 38.81% | Increased |
| 74 | RLAY | 2025-03-31 | Relay Therapeutics, Inc. | 2.69 | 456,014,176.00 | -42.27% | 119,707,854.00 | 2020-07-16 | 49696619 | 18968175 | 4 | baker-casdin-ecor1-tang | 0.80% | Increased |
| 75 | UPB | 2025-03-31 | Upstream Bio, Inc. | 7.37 | 395,333,440.00 | -35.52% | 31,148,731.00 | 2024-10-11 | 49285315 | 8053156 | 3 | deeptrack-ecor1-orbimed | 19.24% | Increased |
| 76 | KOD | 2025-03-31 | Kodiak Sciences Inc | 2.84 | 149,805,168.00 | -62.13% | 32,340,149.00 | 2018-10-04 | 48836424 | 17410490 | 2 | baker-tang | 0.58% | Increased |
| 77 | NGNE | 2025-03-31 | Neurogene Inc. | 11.00 | 164,225,600.00 | -41.52% | 5,545,438.00 | 2014-03-07 | 48825583 | 4169563 | 4 | baker-casdin-deeptrack-ecor1 | 28.64% | Increased |
| 78 | ADMA | 2025-03-31 | ADMA Biologics Inc | 21.31 | 5,083,798,528.00 | 31.87% | 232,872,303.00 | 2013-10-17 | 48076943 | 2423233 | 2 | perceptive-tang | 68.25% | Increased |
| 79 | CDXS | 2025-03-31 | Codexis, Inc. | 2.11 | 174,786,688.00 | -58.22% | 63,397,051.00 | 2010-04-22 | 47344000 | 17600000 | 2 | casdin-opaleye | 3.90% | Increased |
| 80 | TECX | 2025-03-31 | Tectonic Therapeutic, Inc. | 16.16 | 301,589,216.00 | -57.28% | 9,868,448.00 | 2018-06-21 | 46333345 | 2616225 | 4 | baker-deeptrack-ecor1-tang | 181.83% | Increased |
| 81 | BEAM | 2025-03-31 | Beam Therapeutics Inc. | 17.00 | 1,697,280,000.00 | -30.70% | 73,199,019.00 | 2020-02-06 | 45270774 | 2318012 | 4 | casdin-deeptrack-ecor1-tang | 78.31% | Increased |
| 82 | KROS | 2025-03-31 | Keros Therapeutics, Inc. | 14.07 | 570,707,328.00 | 23.31% | 30,728,590.00 | 2020-04-08 | 43880524 | 4306234 | 4 | ecor1-logos-orbimed-tang | 257.00% | Increased |
| 83 | AUTL | 2025-03-31 | Autolus Therapeutics plc | 1.43 | 380,564,448.00 | -34.70% | 138,094,286.00 | 2018-06-22 | 43028192 | 27760124 | 2 | avoro-deeptrack | 15.05% | Increased |
| 84 | SRRK | 2025-03-31 | Scholar Rock Holding Corporatio | 30.75 | 2,916,951,040.00 | -31.48% | 69,786,242.00 | 2018-05-25 | 41417334 | 1288253 | 2 | racapital-orbimed | 660.41% | Increased |
| 85 | CLDX | 2025-03-31 | Celldex Therapeutics, Inc. | 18.30 | 1,214,823,552.00 | -25.64% | 57,785,116.00 | 1986-05-15 | 40794739 | 2247644 | 2 | baker-deeptrack | 25.72% | Increased |
| 86 | CRGX | 2025-03-31 | CARGO Therapeutics, Inc. | 4.26 | 196,183,232.00 | -64.60% | 27,397,475.00 | 2023-11-13 | 38821673 | 9538495 | 4 | cormorant-perceptive-opaleye-tang | 23.47% | Increased |
| 87 | SLRN | 2025-03-31 | ACELYRIN, INC. | 2.23 | 224,583,296.00 | 3.72% | 73,333,894.00 | 2023-05-04 | 38124020 | 15434826 | 3 | orbimed-opaleye-tang | 147.48% | Increased |
| 88 | STOK | 2025-03-31 | Stoke Therapeutics, Inc. | 7.69 | 415,857,504.00 | -21.53% | 37,143,295.00 | 2019-06-19 | 37825194 | 5687999 | 4 | baker-cormorant-opaleye-tang | 9.11% | Increased |
| 89 | ACIU | 2025-03-31 | AC Immune SA | 1.48 | 148,606,800.00 | -44.15% | 39,596,052.00 | 2016-09-23 | 37067955 | 19822436 | 1 | bvf | 1.54% | Increased |
| 90 | RAPP | 2025-03-31 | Rapport Therapeutics, Inc. | 9.26 | 337,956,672.00 | -33.72% | 14,741,641.00 | 2024-06-07 | 36182092 | 3607387 | 3 | cormorant-deeptrack-logos | 4.22% | Increased |
| 91 | URGN | 2025-03-31 | UroGen Pharma Ltd. | 9.87 | 466,014,016.00 | -5.82% | 36,992,561.00 | 2017-05-04 | 35461357 | 3206271 | 1 | racapital | 516.59% | Increased |
| 92 | VSTM | 2025-03-31 | Verastem, Inc. | 7.50 | 386,175,008.00 | 31.81% | 38,014,694.00 | 2012-01-27 | 35172483 | 5832916 | 4 | bvf-casdin-orbimed-tang | 11.47% | Increased |
| 93 | CMPS | 2025-03-31 | COMPASS Pathways Plc - American | 2.85 | 264,118,336.00 | -15.43% | 71,549,218.00 | 2020-09-18 | 35062593 | 12259648 | 3 | deeptrack-logos-tang | 1125.96% | Increased |
| 94 | AVTX | 2025-03-31 | Avalo Therapeutics, Inc. | 4.90 | 52,292,312.00 | -28.68% | 3,682,884.00 | 2015-10-14 | 34847946 | 4350555 | 5 | bvf-deeptrack-perceptive-racapital-orbimed | 13.36% | Increased |
| 95 | NKTX | 2025-03-31 | Nkarta, Inc. | 1.81 | 128,433,248.00 | -25.82% | 48,884,788.00 | 2020-07-10 | 34375073 | 18682105 | 3 | racapital-orbimed-tang | 34.21% | Increased |
| 96 | SERA | 2025-03-31 | Sera Prognostics, Inc. | 3.25 | 122,406,704.00 | -48.66% | 24,854,185.00 | 2021-07-15 | 31393999 | 8530978 | 2 | baker-racapital | 0.75% | Increased |
| 97 | FDMT | 2025-03-31 | 4D Molecular Therapeutics, Inc. | 2.63 | 121,775,320.00 | -44.75% | 34,309,158.00 | 2020-12-11 | 29472135 | 9124500 | 2 | bvf-racapital | 1.45% | Increased |
| 98 | AMLX | 2025-03-31 | Amylyx Pharmaceuticals, Inc. | 3.65 | 323,399,104.00 | 14.78% | 58,959,626.00 | 2022-01-07 | 29461112 | 8322348 | 3 | perceptive-orbimed-tang | 15.23% | Increased |
| 99 | BIOA | 2025-03-31 | BioAge Labs, Inc. | 3.68 | 131,928,000.00 | -21.70% | 23,819,840.00 | 2024-09-26 | 23326972 | 6203982 | 4 | cormorant-racapital-orbimed-tang | 0.38% | Increased |
| 100 | ORIC | 2025-03-31 | Oric Pharmaceuticals, Inc. | 4.77 | 338,797,824.00 | -52.30% | 46,231,360.00 | 2020-04-24 | 22978819 | 4118068 | 2 | ecor1-orbimed | 20.48% | Increased |
| 101 | KRRO | 2025-03-31 | Korro Bio, Inc. | 12.90 | 121,116,808.00 | -66.19% | 4,913,494.00 | 2019-10-03 | 22412189 | 1287317 | 3 | cormorant-deeptrack-orbimed | 41.93% | Increased |
| 102 | CYBN | 2025-03-31 | Cybin Inc. | 6.80 | 142,914,928.00 | -23.60% | 18,315,557.00 | 2019-09-13 | 21302933 | 3360084 | 2 | deeptrack-tang | 17.48% | Increased |
| 103 | ANNX | 2025-03-31 | Annexon, Inc. | 1.46 | 160,176,608.00 | -64.99% | 81,750,277.00 | 2020-07-24 | 21230000 | 11000000 | 2 | bvf-logos | 15.18% | Increased |
| 104 | ACET | 2025-03-31 | Adicet Bio, Inc. | 0.54 | 44,402,276.00 | -38.63% | 61,366,056.00 | 2018-01-26 | 20544873 | 27211752 | 3 | racapital-orbimed-tang | 0.29% | Increased |
| 105 | ERAS | 2025-03-31 | Erasca, Inc. | 1.24 | 351,249,824.00 | -42.33% | 201,634,202.00 | 2021-07-16 | 19440316 | 14190012 | 2 | logos-tang | 8.30% | Increased |
| 106 | PLRX | 2025-03-31 | Pliant Therapeutics, Inc. | 1.46 | 89,405,000.00 | -86.81% | 50,199,674.00 | 2020-06-03 | 19439569 | 14399681 | 3 | cormorant-deeptrack-tang | 79.92% | Increased |
| 107 | AZN | 2025-03-31 | Astrazeneca PLC | 67.59 | 209,553,309,696.00 | -0.54% | 1,544,514,614.00 | 1993-05-12 | 18375000 | 250000 | 1 | tang | 66.67% | Increased |
| 108 | LRMR | 2025-03-31 | Larimar Therapeutics, Inc. | 1.91 | 122,293,288.00 | -44.31% | 31,346,135.00 | 2014-06-19 | 17112771 | 7959428 | 2 | racapital-opaleye | 31.66% | Increased |
| 109 | AVDL | 2025-03-31 | Avadel Pharmaceuticals plc | 8.03 | 775,934,080.00 | 1.65% | 84,810,689.00 | 1996-06-07 | 16423425 | 2097500 | 1 | tang | 40.07% | Increased |
| 110 | MRNA | 2025-03-31 | Moderna, Inc. | 24.71 | 9,555,387,392.00 | -31.14% | 359,997,079.00 | 2018-12-07 | 15034005 | 530300 | 2 | casdin-tang | 11.64% | Increased |
| 111 | TDOC | 2025-03-31 | Teladoc Health, Inc. | 7.25 | 1,270,765,440.00 | -25.26% | 159,717,484.00 | 2015-06-30 | 13532000 | 1700000 | 2 | casdin-tang | 21.43% | Increased |
| 112 | IKNA | 2025-03-31 | Ikena Oncology, Inc. | 1.10 | 53,083,912.00 | -28.57% | 7,895,027.00 | 2021-03-26 | 12878637 | 10061435 | 3 | bvf-deeptrack-orbimed | 33.34% | Increased |
| 113 | KALA | 2025-03-31 | KALA BIO, Inc. | 3.46 | 22,293,042.00 | -55.01% | 3,851,888.00 | 2017-07-20 | 11932903 | 2082531 | 3 | baker-cormorant-perceptive | 15.38% | Increased |
| 114 | DERM | 2025-03-31 | Journey Medical Corporation | 6.03 | 139,319,536.00 | 59.52% | 10,945,727.00 | 2021-11-12 | 11351122 | 1923919 | 2 | opaleye-tang | 11.49% | Increased |
| 115 | RGLS | 2025-03-31 | Regulus Therapeutics Inc. | 2.06 | 136,461,408.00 | 63.49% | 48,557,725.00 | 2012-10-09 | 10424064 | 5956608 | 2 | baker-deeptrack | 65.49% | Increased |
| 116 | ELAN | 2025-03-31 | Elanco Animal Health Incorporat | 8.44 | 4,190,105,088.00 | -29.90% | 490,780,682.00 | 2018-09-20 | 8401050 | 800100 | 1 | tang | 0.01% | Increased |
| 117 | CTMX | 2025-03-31 | CytomX Therapeutics, Inc. | 0.66 | 52,545,540.00 | -24.68% | 73,975,451.00 | 2015-10-08 | 8231249 | 12946286 | 3 | bvf-racapital-tang | 3.24% | Increased |
| 118 | ALLK | 2025-03-31 | Allakos Inc. | 0.33 | 29,462,902.00 | -70.63% | 51,401,358.00 | 2018-07-19 | 8052216 | 35378805 | 4 | bvf-deeptrack-logos-tang | 32.68% | Increased |
| 119 | BLCO | 2025-03-31 | Bausch + Lomb Corporation | 11.40 | 4,027,311,872.00 | -34.37% | 41,284,904.00 | 2022-05-06 | 7975000 | 550000 | 1 | tang | 22.22% | Increased |
| 120 | SRZN | 2025-03-31 | Surrozen, Inc. | 9.00 | 76,451,216.00 | -20.49% | 2,128,396.00 | 2021-01-11 | 7918656 | 679130 | 1 | racapital | 140.33% | Increased |
| 121 | PHAT | 2025-03-31 | Phathom Pharmaceuticals, Inc. | 4.03 | 280,637,120.00 | -40.65% | 56,653,838.00 | 2019-10-25 | 7524000 | 1200000 | 1 | tang | 140.00% | Increased |
| 122 | VIGL | 2025-03-31 | Vigil Neuroscience, Inc. | 1.49 | 69,540,536.00 | -14.37% | 27,996,853.00 | 2022-01-07 | 7144267 | 4013633 | 1 | bvf | 121.30% | Increased |
| 123 | REGN | 2025-03-31 | Regeneron Pharmaceuticals, Inc. | 563.16 | 61,567,463,424.00 | -18.12% | 102,996,273.00 | 1991-04-02 | 6342300 | 10000 | 1 | tang | 400.00% | Increased |
| 124 | ALGS | 2025-03-31 | Aligos Therapeutics, Inc. | 4.08 | 24,946,384.00 | -88.12% | 4,373,872.00 | 2020-10-16 | 6244137 | 756865 | 4 | baker-deeptrack-ecor1-tang | 29.88% | Increased |
| 125 | DCTH | 2025-03-31 | Delcath Systems, Inc. | 10.66 | 356,391,520.00 | -16.65% | 31,032,851.00 | 2018-05-03 | 5886632 | 462422 | 1 | perceptive | 824.84% | Increased |
| 126 | ZNTL | 2025-03-31 | Zentalis Pharmaceuticals, Inc. | 1.23 | 88,328,152.00 | -51.95% | 45,013,608.00 | 2020-04-03 | 5541150 | 3485000 | 2 | opaleye-tang | 97.17% | Increased |
| 127 | HRTX | 2025-03-31 | Heron Therapeutics, Inc. | 1.84 | 280,287,200.00 | 12.88% | 115,963,945.00 | 1987-08-26 | 4918010 | 2235459 | 1 | tang | 4.45% | Increased |
| 128 | IGMS | 2025-03-31 | IGM Biosciences, Inc. | 1.22 | 72,925,992.00 | -28.65% | 10,672,898.00 | 2019-09-18 | 4709546 | 4095257 | 1 | baker | 0.02% | Increased |
| 129 | CHRS | 2025-03-31 | Coherus BioSciences, Inc. | 1.12 | 129,804,640.00 | -15.15% | 114,413,369.00 | 2014-11-06 | 4113571 | 5097362 | 1 | tang | 39.65% | Increased |
| 130 | ATRA | 2025-03-31 | Atara Biotherapeutics, Inc. | 6.17 | 36,149,476.00 | 1.98% | 4,197,850.00 | 2014-10-16 | 3851371 | 648379 | 2 | ecor1-tang | 6.76% | Increased |
| 131 | TRAW | 2025-03-31 | Traws Pharma, Inc. | 2.00 | 10,066,580.00 | -72.71% | 4,277,814.00 | 2013-07-25 | 2362817 | 1027312 | 2 | perceptive-orbimed | 33.47% | Increased |
| 132 | JNJ | 2025-03-31 | Johnson & Johnson | 157.47 | 379,479,097,344.00 | 6.29% | 2,403,933,039.00 | 1962-01-02 | 2030379 | 12243 | 1 | tang | 53.83% | Increased |
| 133 | VTRS | 2025-03-31 | Viatris Inc. | 7.54 | 9,000,422,400.00 | -36.10% | 1,185,535,855.00 | 1980-03-17 | 1471811 | 168979 | 1 | tang | 47.82% | Increased |
| 134 | KRON | 2025-03-31 | Kronos Bio, Inc. | 0.78 | 47,555,976.00 | -17.89% | 43,754,556.00 | 2020-10-09 | 1212133 | 1469252 | 2 | casdin-tang | 30.34% | Increased |
| 135 | PYXS | 2025-03-31 | Pyxis Oncology, Inc. | 0.96 | 59,046,716.00 | -37.34% | 44,339,556.00 | 2021-10-08 | 1077890 | 1100000 | 1 | tang | 483.67% | Increased |
| 136 | LXRX | 2025-03-31 | Lexicon Pharmaceuticals, Inc. | 0.51 | 184,288,624.00 | -35.47% | 182,278,875.00 | 2000-04-07 | 530043 | 1150268 | 1 | tang | 35.28% | Increased |
| 137 | OTLK | 2025-03-31 | Outlook Therapeutics, Inc. | 1.45 | 47,299,292.00 | -36.82% | 20,356,522.00 | 2016-06-14 | 488000 | 400000 | 1 | tang | 119.18% | Increased |
| 138 | RVPH | 2025-03-31 | Reviva Pharmaceuticals Holdings | 0.68 | 31,535,412.00 | -64.68% | 40,746,018.00 | 2018-10-18 | 486752 | 510329 | 1 | tang | 200.19% | Increased |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by Increase in Share %
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | PFE | 2025-03-31 | Pfizer, Inc. | 22.14 | 125,565,902,848.00 | -16.89% | 5,657,705,935.00 | 1972-06-01 | 99256787 | 3917000 | 2 | orbimed-tang | 9028.83% |
| 1 | CMPS | 2025-03-31 | COMPASS Pathways Plc - American | 2.85 | 264,118,336.00 | -15.43% | 71,549,218.00 | 2020-09-18 | 35062593 | 12259648 | 3 | deeptrack-logos-tang | 1125.96% |
| 2 | DCTH | 2025-03-31 | Delcath Systems, Inc. | 10.66 | 356,391,520.00 | -16.65% | 31,032,851.00 | 2018-05-03 | 5886632 | 462422 | 1 | perceptive | 824.84% |
| 3 | SRRK | 2025-03-31 | Scholar Rock Holding Corporatio | 30.75 | 2,916,951,040.00 | -31.48% | 69,786,242.00 | 2018-05-25 | 41417334 | 1288253 | 2 | racapital-orbimed | 660.41% |
| 4 | URGN | 2025-03-31 | UroGen Pharma Ltd. | 9.87 | 466,014,016.00 | -5.82% | 36,992,561.00 | 2017-05-04 | 35461357 | 3206271 | 1 | racapital | 516.59% |
| 5 | PYXS | 2025-03-31 | Pyxis Oncology, Inc. | 0.96 | 59,046,716.00 | -37.34% | 44,339,556.00 | 2021-10-08 | 1077890 | 1100000 | 1 | tang | 483.67% |
| 6 | REGN | 2025-03-31 | Regeneron Pharmaceuticals, Inc. | 563.16 | 61,567,463,424.00 | -18.12% | 102,996,273.00 | 1991-04-02 | 6342300 | 10000 | 1 | tang | 400.00% |
| 7 | KROS | 2025-03-31 | Keros Therapeutics, Inc. | 14.07 | 570,707,328.00 | 23.31% | 30,728,590.00 | 2020-04-08 | 43880524 | 4306234 | 4 | ecor1-logos-orbimed-tang | 257.00% |
| 8 | RVPH | 2025-03-31 | Reviva Pharmaceuticals Holdings | 0.68 | 31,535,412.00 | -64.68% | 40,746,018.00 | 2018-10-18 | 486752 | 510329 | 1 | tang | 200.19% |
| 9 | TECX | 2025-03-31 | Tectonic Therapeutic, Inc. | 16.16 | 301,589,216.00 | -57.28% | 9,868,448.00 | 2018-06-21 | 46333345 | 2616225 | 4 | baker-deeptrack-ecor1-tang | 181.83% |
| 10 | GERN | 2025-03-31 | Geron Corporation | 1.27 | 808,879,552.00 | -57.09% | 601,237,820.00 | 1996-07-31 | 169423431 | 106555617 | 3 | deeptrack-logos-racapital | 179.02% |
| 11 | DNTH | 2025-03-31 | Dianthus Therapeutics, Inc. | 17.61 | 565,737,088.00 | -23.57% | 14,121,907.00 | 2018-06-21 | 99572764 | 5489127 | 3 | deeptrack-racapital-tang | 157.57% |
| 12 | SLRN | 2025-03-31 | ACELYRIN, INC. | 2.23 | 224,583,296.00 | 3.72% | 73,333,894.00 | 2023-05-04 | 38124020 | 15434826 | 3 | orbimed-opaleye-tang | 147.48% |
| 13 | BPMC | 2025-03-31 | Blueprint Medicines Corporation | 84.69 | 5,412,199,424.00 | -24.36% | 63,174,287.00 | 2015-04-30 | 369651217 | 4176378 | 2 | avoro-casdin | 144.04% |
| 14 | SRZN | 2025-03-31 | Surrozen, Inc. | 9.00 | 76,451,216.00 | -20.49% | 2,128,396.00 | 2021-01-11 | 7918656 | 679130 | 1 | racapital | 140.33% |
| 15 | PHAT | 2025-03-31 | Phathom Pharmaceuticals, Inc. | 4.03 | 280,637,120.00 | -40.65% | 56,653,838.00 | 2019-10-25 | 7524000 | 1200000 | 1 | tang | 140.00% |
| 16 | VIGL | 2025-03-31 | Vigil Neuroscience, Inc. | 1.49 | 69,540,536.00 | -14.37% | 27,996,853.00 | 2022-01-07 | 7144267 | 4013633 | 1 | bvf | 121.30% |
| 17 | OTLK | 2025-03-31 | Outlook Therapeutics, Inc. | 1.45 | 47,299,292.00 | -36.82% | 20,356,522.00 | 2016-06-14 | 488000 | 400000 | 1 | tang | 119.18% |
| 18 | ITOS | 2025-03-31 | iTeos Therapeutics, Inc. | 6.51 | 248,644,896.00 | -19.23% | 29,147,629.00 | 2020-07-24 | 56197144 | 9413257 | 3 | bvf-racapital-tang | 102.92% |
| 19 | BBIO | 2025-03-31 | BridgeBio Pharma, Inc. | 33.87 | 6,441,700,864.00 | -6.13% | 139,058,316.00 | 2019-06-27 | 165936000 | 4800000 | 2 | cormorant-deeptrack | 98.42% |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by the Highest Fund Number
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | EWTX | 2025-03-31 | Edgewise Therapeutics, Inc. | 11.42 | 1,200,710,272.00 | -54.92% | 54,187,991.00 | 2021-03-26 | 942283584 | 42831072 | 8 | baker-cormorant-deeptrack-perceptive-racapital-orbimed-opaleye-tang | 12.51% |
| 1 | GPCR | 2025-03-31 | Structure Therapeutics Inc. | 15.90 | 911,750,528.00 | -36.80% | 148,959,516.00 | 2023-02-03 | 164919779 | 9527428 | 7 | baker-bvf-casdin-deeptrack-logos-racapital-orbimed | 12.06% |
| 2 | DYN | 2025-03-31 | Dyne Therapeutics, Inc. | 7.04 | 796,371,840.00 | -53.96% | 97,275,317.00 | 2020-09-17 | 170649690 | 16314502 | 7 | baker-casdin-deeptrack-logos-perceptive-racapital-orbimed | 37.92% |
| 3 | PCVX | 2025-03-31 | Vaxcyte, Inc. | 30.65 | 3,946,555,136.00 | -65.24% | 119,134,116.00 | 2020-06-12 | 595158054 | 15761601 | 7 | avoro-baker-cormorant-deeptrack-perceptive-racapital-tang | 23.80% |
| 4 | RNA | 2025-03-31 | Avidity Biosciences, Inc. | 26.66 | 3,204,851,968.00 | -13.55% | 92,698,110.00 | 2020-06-12 | 563562483 | 19090870 | 7 | avoro-casdin-cormorant-ecor1-logos-racapital-orbimed | 2.83% |
| 5 | INSM | 2025-03-31 | Insmed Incorporated | 72.65 | 13,209,223,168.00 | -5.34% | 166,410,802.00 | 2000-06-01 | 533903054 | 6998336 | 7 | baker-cormorant-deeptrack-perceptive-racapital-orbimed-tang | 5.31% |
| 6 | JANX | 2025-03-31 | Janux Therapeutics, Inc. | 28.80 | 1,702,226,816.00 | -36.09% | 37,290,619.00 | 2021-06-11 | 491089203 | 18188489 | 7 | cormorant-ecor1-logos-perceptive-racapital-orbimed-tang | 8.19% |
| 7 | IRON | 2025-03-31 | Disc Medicine, Inc. | 38.73 | 1,338,857,344.00 | -34.07% | 26,301,510.00 | 2020-08-12 | 183594434 | 3698518 | 6 | baker-logos-perceptive-racapital-orbimed-opaleye | 79.31% |
| 8 | XENE | 2025-03-31 | Xenon Pharmaceuticals Inc. | 31.40 | 2,403,443,968.00 | -17.91% | 70,775,310.00 | 2014-11-05 | 302361825 | 9012275 | 6 | avoro-baker-deeptrack-logos-perceptive-orbimed | 11.23% |
| 9 | SEPN | 2025-03-31 | Septerna, Inc. | 5.72 | 254,211,088.00 | -66.35% | 19,629,806.00 | 2024-10-25 | 88760012 | 15329881 | 6 | avoro-bvf-casdin-deeptrack-logos-racapital | 5.96% |
| 10 | AKRO | 2025-03-31 | Akero Therapeutics, Inc. | 37.63 | 2,996,104,192.00 | 46.99% | 66,438,220.00 | 2019-06-20 | 257932205 | 6371843 | 6 | baker-deeptrack-ecor1-logos-perceptive-orbimed | 37.36% |
| 11 | MBX | 2025-03-31 | MBX Biosciences, Inc. | 7.41 | 247,674,800.00 | -40.53% | 13,610,404.00 | 2024-09-13 | 79279126 | 10742429 | 6 | cormorant-deeptrack-ecor1-racapital-orbimed-opaleye | 4.28% |
| 12 | NRIX | 2025-03-31 | Nurix Therapeutics, Inc. | 10.24 | 780,652,544.00 | -47.76% | 59,122,228.00 | 2020-07-24 | 132200771 | 11128011 | 5 | baker-deeptrack-perceptive-racapital-opaleye | 24.69% |
| 13 | AVTX | 2025-03-31 | Avalo Therapeutics, Inc. | 4.90 | 52,292,312.00 | -28.68% | 3,682,884.00 | 2015-10-14 | 34847946 | 4350555 | 5 | bvf-deeptrack-perceptive-racapital-orbimed | 13.36% |
| 14 | ZYME | 2025-03-31 | Zymeworks Inc. | 10.63 | 739,602,432.00 | -23.85% | 38,672,223.00 | 2017-04-28 | 294274127 | 24708155 | 5 | bvf-ecor1-perceptive-opaleye-tang | 9.49% |
| 15 | IONS | 2025-03-31 | Ionis Pharmaceuticals, Inc. | 28.40 | 4,514,605,568.00 | -13.10% | 157,589,727.00 | 1991-05-17 | 287388649 | 9525643 | 5 | baker-bvf-deeptrack-orbimed-tang | 81.12% |
| 16 | SLDB | 2025-03-31 | Solid Biosciences Inc. | 2.55 | 197,607,152.00 | -21.78% | 39,269,557.00 | 2018-01-26 | 66069205 | 17856542 | 5 | casdin-ecor1-logos-perceptive-racapital | 58.91% |
| 17 | ELVN | 2025-03-31 | Enliven Therapeutics, Inc. | 16.51 | 809,062,656.00 | -25.19% | 26,934,302.00 | 2020-03-12 | 185254865 | 9413357 | 5 | baker-cormorant-logos-racapital-orbimed | 1.07% |
| 18 | MRUS | 2025-03-31 | Merus N.V. | 43.05 | 2,974,691,328.00 | 8.34% | 55,639,246.00 | 2016-05-19 | 200095229 | 4753985 | 5 | avoro-baker-cormorant-perceptive-tang | 6.47% |
| 19 | RVMD | 2025-03-31 | Revolution Medicines, Inc. | 36.76 | 6,834,161,152.00 | -8.47% | 168,212,518.00 | 2020-02-13 | 647699339 | 18317289 | 5 | baker-bvf-casdin-logos-tang | 5.47% |
------------------------------------------------------------ ------------------------------------------------------------ Closed Positions (No longer in any in any of the funds) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | BMRN | 2024-12-31 | BioMarin Pharmaceutical Inc. | 59.17 | 11,346,083,840.00 | -5.37% | 178,517,719.00 | 1999-07-26 | 96130125 | 1462500 | 1 | avoro | Closed |
| 1 | MRK | 2024-12-31 | Merck & Company, Inc. | 78.00 | 196,278,419,456.00 | -18.95% | 2,522,019,842.00 | 1962-01-02 | 82558452 | 829900 | 1 | orbimed | Closed |
| 2 | UHS | 2024-12-31 | Universal Health Services, Inc. | 175.41 | 11,437,205,504.00 | -5.56% | 55,084,625.00 | 1981-07-09 | 48317806 | 269300 | 1 | orbimed | Closed |
| 3 | EVH | 2024-12-31 | Evolent Health, Inc | 10.03 | 1,169,407,744.00 | -19.05% | 113,203,505.00 | 2015-06-05 | 40243466 | 3577197 | 1 | racapital | Closed |
| 4 | PRCT | 2024-12-31 | PROCEPT BioRobotics Corporation | 52.07 | 2,854,409,728.00 | -37.20% | 52,527,278.00 | 2021-09-15 | 23403863 | 290659 | 1 | perceptive | Closed |
| 5 | MRSN | 2024-12-31 | Mersana Therapeutics, Inc. | 0.35 | 44,206,616.00 | -35.51% | 79,932,309.00 | 2017-06-28 | 17752184 | 12414115 | 2 | baker-ecor1 | Closed |
| 6 | PEN | 2024-12-31 | Penumbra, Inc. | 272.32 | 10,488,649,728.00 | 10.28% | 37,159,032.00 | 2015-09-18 | 17416308 | 73338 | 1 | perceptive | Closed |
| 7 | MEDP | 2024-12-31 | Medpace Holdings, Inc. | 296.28 | 8,956,069,888.00 | -14.74% | 24,275,037.00 | 2016-08-11 | 14917127 | 44900 | 1 | orbimed | Closed |
| 8 | YMAB | 2024-12-31 | Y-mAbs Therapeutics, Inc. | 4.83 | 218,403,904.00 | -25.69% | 27,846,710.00 | 2018-09-21 | 11157750 | 1425000 | 2 | cormorant-logos | Closed |
| 9 | JSPR | 2024-12-31 | Jasper Therapeutics, Inc. | 4.16 | 62,491,932.00 | -37.82% | 9,909,493.00 | 2020-01-10 | 8552000 | 400000 | 1 | opaleye | Closed |
| 10 | ZBIO | 2024-12-31 | Zenas BioPharma, Inc. | 7.93 | 331,468,448.00 | -2.34% | 20,878,768.00 | 2024-09-13 | 6093647 | 744035 | 1 | perceptive | Closed |
| 11 | IRTC | 2024-12-31 | iRhythm Technologies, Inc. | 102.09 | 3,206,605,824.00 | 7.93% | 31,001,606.00 | 2016-10-20 | 5874846 | 65153 | 1 | perceptive | Closed |
| 12 | MIST | 2024-12-31 | Milestone Pharmaceuticals Inc. | 0.89 | 47,426,368.00 | -58.46% | 53,004,370.00 | 2019-05-09 | 4720000 | 2000000 | 1 | orbimed | Closed |
| 13 | VYNE | 2024-12-31 | VYNE Therapeutics Inc. | 1.55 | 23,651,394.00 | -48.51% | 10,466,058.00 | 2018-01-25 | 4671026 | 1394336 | 1 | cormorant | Closed |
| 14 | VERU | 2024-12-31 | Veru Inc. | 0.54 | 80,379,352.00 | -15.94% | 125,582,765.00 | 1999-02-11 | 4217294 | 6483157 | 1 | perceptive | Closed |
| 15 | CATX | 2024-12-31 | Perspective Therapeutics, Inc. | 1.95 | 144,401,008.00 | -42.65% | 54,412,552.00 | 2005-11-10 | 3796939 | 1190263 | 1 | perceptive | Closed |
| 16 | LCTX | 2024-12-31 | Lineage Cell Therapeutics, Inc. | 0.41 | 93,625,960.00 | -30.51% | 177,830,177.00 | 1992-03-05 | 3636514 | 7236843 | 1 | perceptive | Closed |
| 17 | ARDT | 2024-12-31 | Ardent Health Partners, Inc. | 11.78 | 1,681,595,008.00 | -26.60% | 24,109,050.00 | 2024-07-18 | 3518480 | 206000 | 1 | orbimed | Closed |
| 18 | OMER | 2024-12-31 | Omeros Corporation | 6.78 | 393,673,248.00 | -25.90% | 55,488,186.00 | 2009-10-08 | 2964000 | 300000 | 1 | cormorant | Closed |
| 19 | ARCT | 2024-12-31 | Arcturus Therapeutics Holdings | 10.53 | 285,571,488.00 | -35.83% | 24,834,707.00 | 2013-05-22 | 2568053 | 151329 | 1 | baker | Closed |
| 20 | VRCA | 2024-12-31 | Verrica Pharmaceuticals Inc. | 0.49 | 45,222,480.00 | -31.69% | 17,976,029.00 | 2018-06-15 | 2274768 | 3249669 | 1 | perceptive | Closed |
| 21 | LYEL | 2024-12-31 | Lyell Immunopharma, Inc. | 0.44 | 129,457,912.00 | -26.18% | 201,520,273.00 | 2021-06-17 | 1986319 | 3103623 | 1 | orbimed | Closed |
| 22 | NKTR | 2024-12-31 | Nektar Therapeutics | 0.64 | 118,436,584.00 | -29.29% | 173,991,966.00 | 1994-05-03 | 1837678 | 1975998 | 1 | deeptrack | Closed |
| 23 | TRIB | 2024-12-31 | Trinity Biotech plc | 0.71 | 13,589,423.00 | -6.84% | 181,493,781.00 | 1992-10-21 | 1575200 | 1790000 | 1 | perceptive | Closed |
| 24 | RGNX | 2024-12-31 | REGENXBIO Inc. | 5.94 | 297,694,400.00 | -21.53% | 41,056,108.00 | 2015-09-17 | 618400 | 80000 | 1 | opaleye | Closed |
| 25 | EDIT | 2024-12-31 | Editas Medicine, Inc. | 1.28 | 107,148,160.00 | 5.79% | 82,676,740.00 | 2016-02-03 | 508000 | 400000 | 1 | tang | Closed |
| 26 | RLMD | 2024-12-31 | Relmada Therapeutics, Inc. | 0.29 | 9,618,925.00 | -21.89% | 30,568,156.00 | 2014-06-20 | 104429 | 200825 | 1 | tang | Closed |
| 27 | IMRX | 2024-12-31 | Immuneering Corporation | 1.29 | 46,294,616.00 | -35.82% | 27,234,477.00 | 2021-07-30 | 26561 | 12073 | 1 | tang | Closed |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ARGX | 2025-03-31 | argenx SE | 596.20 | 36,474,028,032.00 | -7.91% | 60,989,637.00 | 2017-05-18 | 934641839 | 1579147 | 4 | avoro-baker-perceptive-orbimed | -1.77% | Decreased |
| 1 | UTHR | 2025-03-31 | United Therapeutics Corporation | 291.38 | 13,312,861,184.00 | -21.15% | 41,324,592.00 | 1999-06-17 | 824622250 | 2675000 | 1 | avoro | -3.09% | Decreased |
| 2 | RYTM | 2025-03-31 | Rhythm Pharmaceuticals, Inc. | 61.74 | 3,903,431,424.00 | 7.34% | 46,955,630.00 | 2017-10-09 | 808181301 | 15257340 | 6 | baker-cormorant-perceptive-racapital-orbimed-opaleye | -11.03% | Decreased |
| 3 | KRYS | 2025-03-31 | Krystal Biotech, Inc. | 168.57 | 4,871,403,520.00 | 11.23% | 22,823,920.00 | 2017-09-20 | 496636350 | 2754500 | 2 | avoro-orbimed | -2.40% | Decreased |
| 4 | ACLX | 2025-03-31 | Arcellx, Inc. | 59.15 | 3,249,937,664.00 | -12.19% | 32,601,579.00 | 2022-02-04 | 460053128 | 7013005 | 3 | cormorant-perceptive-racapital | -7.31% | Decreased |
| 5 | VRNA | 2025-03-31 | Verona Pharma plc | 65.46 | 8,622,652,416.00 | 21.92% | 493,924,450.00 | 2017-04-28 | 430918249 | 6787183 | 2 | baker-perceptive | -24.66% | Decreased |
| 6 | FOLD | 2025-03-31 | Amicus Therapeutics, Inc. | 6.83 | 2,098,449,152.00 | -28.18% | 250,897,044.00 | 2007-05-31 | 361079404 | 44249927 | 3 | avoro-perceptive-orbimed | -10.98% | Decreased |
| 7 | AXSM | 2025-03-31 | Axsome Therapeutics, Inc. | 104.46 | 5,094,033,408.00 | 8.61% | 36,674,021.00 | 2015-11-19 | 312804925 | 2682028 | 4 | bvf-cormorant-perceptive-orbimed | -20.58% | Decreased |
| 8 | SLNO | 2025-03-31 | Soleno Therapeutics, Inc. | 69.98 | 3,209,093,888.00 | 42.32% | 31,320,071.00 | 2014-11-13 | 309492963 | 4331602 | 4 | avoro-logos-perceptive-tang | -2.13% | Decreased |
| 9 | BSX | 2025-03-31 | Boston Scientific Corporation | 93.67 | 138,544,480,256.00 | -0.99% | 1,471,454,074.00 | 1992-05-19 | 296910016 | 2943200 | 2 | perceptive-orbimed | -6.87% | Decreased |
| 10 | GH | 2025-03-31 | Guardant Health, Inc. | 44.97 | 5,550,242,304.00 | -0.35% | 111,589,027.00 | 2018-10-04 | 242552515 | 5693721 | 2 | casdin-deeptrack | -15.89% | Decreased |
| 11 | JAZZ | 2025-03-31 | Jazz Pharmaceuticals plc | 102.78 | 6,242,086,400.00 | -15.36% | 58,903,824.00 | 2007-06-01 | 235446626 | 1896469 | 2 | ecor1-tang | -6.18% | Decreased |
| 12 | ALKS | 2025-03-31 | Alkermes plc | 27.00 | 4,450,571,776.00 | -10.30% | 160,028,503.00 | 1991-07-16 | 228937071 | 6933285 | 2 | avoro-baker | -2.78% | Decreased |
| 13 | CRNX | 2025-03-31 | Crinetics Pharmaceuticals, Inc. | 30.42 | 2,830,535,168.00 | -21.52% | 91,642,575.00 | 2018-07-18 | 209193005 | 6237120 | 4 | cormorant-ecor1-logos-orbimed | -3.62% | Decreased |
| 14 | OCUL | 2025-03-31 | Ocular Therapeutix, Inc. | 7.31 | 1,162,450,816.00 | -9.64% | 124,121,633.00 | 2014-07-25 | 199120880 | 27165195 | 5 | avoro-deeptrack-logos-perceptive-opaleye | -8.89% | Decreased |
| 15 | CYTK | 2025-03-31 | Cytokinetics, Incorporated | 39.48 | 4,705,542,144.00 | -13.84% | 117,836,397.00 | 2004-04-30 | 188212101 | 4683058 | 3 | deeptrack-orbimed-tang | -7.89% | Decreased |
| 16 | MIRM | 2025-03-31 | Mirum Pharmaceuticals, Inc. | 39.10 | 1,933,663,104.00 | -18.51% | 38,862,861.00 | 2019-07-18 | 181714581 | 4033620 | 2 | bvf-tang | -4.51% | Decreased |
| 17 | ISRG | 2025-03-31 | Intuitive Surgical, Inc. | 493.60 | 176,844,554,240.00 | -8.55% | 354,513,456.00 | 2000-06-16 | 164240942 | 331619 | 2 | perceptive-orbimed | -28.66% | Decreased |
| 18 | NUVL | 2025-03-31 | Nuvalent, Inc. | 66.29 | 4,746,225,152.00 | -7.75% | 40,974,058.00 | 2021-07-29 | 154887011 | 2183968 | 3 | logos-perceptive-tang | -19.96% | Decreased |
| 19 | CNTA | 2025-03-31 | Centessa Pharmaceuticals plc | 11.57 | 1,540,938,880.00 | -24.18% | 93,006,626.00 | 2021-05-28 | 152847508 | 10629173 | 5 | avoro-baker-cormorant-perceptive-tang | -7.48% | Decreased |
| 20 | VERA | 2025-03-31 | Vera Therapeutics, Inc. | 22.43 | 1,430,399,232.00 | -35.49% | 50,541,557.00 | 2021-05-14 | 152117819 | 6332965 | 3 | avoro-orbimed-tang | -12.38% | Decreased |
| 21 | NBIX | 2025-03-31 | Neurocrine Biosciences, Inc. | 101.38 | 10,030,354,432.00 | -30.50% | 98,515,061.00 | 1996-05-23 | 131026714 | 1184690 | 3 | perceptive-orbimed-tang | -14.66% | Decreased |
| 22 | ALNY | 2025-03-31 | Alnylam Pharmaceuticals, Inc. | 234.56 | 30,358,396,928.00 | -11.48% | 124,460,110.00 | 2004-06-01 | 125856322 | 466100 | 2 | casdin-orbimed | -16.11% | Decreased |
| 23 | BCYC | 2025-03-31 | Bicycle Therapeutics plc | 7.39 | 511,405,728.00 | -45.50% | NaN | 2019-05-23 | 115938167 | 13655850 | 4 | baker-deeptrack-ecor1-racapital | -4.92% | Decreased |
| 24 | PRAX | 2025-03-31 | Praxis Precision Medicines, Inc | 29.74 | 599,653,568.00 | -53.55% | 16,083,216.00 | 2020-10-16 | 115784761 | 3057427 | 3 | baker-cormorant-perceptive | -25.73% | Decreased |
| 25 | EOLS | 2025-03-31 | Evolus, Inc. Common Stock | 10.79 | 686,101,568.00 | -19.96% | 56,934,307.00 | 2018-02-08 | 109792288 | 9126541 | 2 | perceptive-tang | -10.02% | Decreased |
| 26 | APGE | 2025-03-31 | Apogee Therapeutics, Inc. | 31.80 | 1,847,179,264.00 | -22.27% | 39,041,674.00 | 2023-07-14 | 108054759 | 2892258 | 3 | perceptive-racapital-tang | -4.13% | Decreased |
| 27 | HROW | 2025-03-31 | Harrow, Inc. | 24.09 | 858,909,696.00 | -30.66% | 26,130,229.00 | 2007-09-28 | 105203000 | 3955000 | 1 | opaleye | -0.88% | Decreased |
| 28 | MLYS | 2025-03-31 | Mineralys Therapeutics, Inc. | 13.40 | 869,341,056.00 | 43.16% | 33,142,194.00 | 2023-02-10 | 100794806 | 6347280 | 2 | racapital-tang | -1.78% | Decreased |
| 29 | IMTX | 2025-03-31 | Immatics N.V. | 4.26 | 517,803,040.00 | -21.11% | 61,326,922.00 | 2018-12-12 | 96950334 | 21496748 | 4 | baker-perceptive-racapital-orbimed | -0.76% | Decreased |
| 30 | CRSP | 2025-03-31 | CRISPR Therapeutics AG | 37.77 | 3,261,938,176.00 | -9.01% | 85,368,761.00 | 2016-10-19 | 78605046 | 2309875 | 3 | baker-ecor1-tang | -22.06% | Decreased |
| 31 | ABCL | 2025-03-31 | AbCellera Biologics Inc. | 2.40 | 715,171,200.00 | -20.00% | 202,801,468.00 | 2020-12-11 | 76503290 | 34306408 | 3 | baker-orbimed-tang | -2.69% | Decreased |
| 32 | BCRX | 2025-03-31 | BioCryst Pharmaceuticals, Inc. | 7.40 | 1,546,304,000.00 | -2.76% | 195,072,537.00 | 1994-03-04 | 71250000 | 9500000 | 2 | avoro-tang | -24.99% | Decreased |
| 33 | XOMA | 2025-03-31 | XOMA Royalty Corporation | 19.97 | 239,214,624.00 | -21.38% | 8,907,733.00 | 1986-06-06 | 64494855 | 3236069 | 2 | bvf-opaleye | -16.68% | Decreased |
| 34 | VERV | 2025-03-31 | Verve Therapeutics, Inc. | 3.26 | 289,474,304.00 | -40.73% | 64,970,975.00 | 2021-06-17 | 63254060 | 13841151 | 4 | baker-bvf-casdin-ecor1 | -2.47% | Decreased |
| 35 | THC | 2025-03-31 | Tenet Healthcare Corporation | 123.79 | 11,775,028,224.00 | -4.24% | 93,879,671.00 | 1980-03-17 | 62542500 | 465000 | 1 | orbimed | -41.29% | Decreased |
| 36 | DRUG | 2025-03-31 | Bright Minds Biosciences Inc. | 28.83 | 203,078,224.00 | -18.58% | 2,524,284.00 | 2021-03-22 | 61694380 | 1710407 | 3 | cormorant-perceptive-racapital | -21.14% | Decreased |
| 37 | AVBP | 2025-03-31 | ArriVent BioPharma, Inc. | 18.15 | 617,394,048.00 | -28.59% | 15,838,962.00 | 2024-01-26 | 55975295 | 3027328 | 1 | orbimed | -16.21% | Decreased |
| 38 | IOVA | 2025-03-31 | Iovance Biotherapeutics, Inc. | 3.06 | 1,003,303,552.00 | -47.96% | 251,861,761.00 | 2010-10-15 | 48324254 | 14511788 | 2 | perceptive-tang | -44.43% | Decreased |
| 39 | ILMN | 2025-03-31 | Illumina, Inc. | 71.20 | 11,268,325,376.00 | -49.61% | 157,885,200.00 | 2000-07-28 | 47207300 | 595000 | 1 | casdin | -20.67% | Decreased |
| 40 | EXAS | 2025-03-31 | Exact Sciences Corporation | 41.58 | 7,723,693,568.00 | -23.37% | 184,254,502.00 | 2001-02-01 | 46961685 | 1084816 | 2 | casdin-orbimed | -18.42% | Decreased |
| 41 | BNTX | 2025-03-31 | BioNTech SE | 98.76 | 23,741,212,672.00 | -15.77% | 92,355,164.00 | 2019-10-10 | 46898723 | 515031 | 3 | baker-logos-tang | -16.26% | Decreased |
| 42 | SWTX | 2025-03-31 | SpringWorks Therapeutics, Inc. | 37.92 | 2,843,408,384.00 | 4.32% | 73,786,642.00 | 2019-09-13 | 45209640 | 1024465 | 2 | orbimed-tang | -83.87% | Decreased |
| 43 | OLMA | 2025-03-31 | Olema Pharmaceuticals, Inc. | 3.77 | 257,615,808.00 | -22.11% | 41,105,755.00 | 2020-11-19 | 44922980 | 11947601 | 3 | bvf-deeptrack-logos | -14.78% | Decreased |
| 44 | CDTX | 2025-03-31 | Cidara Therapeutics, Inc. | 19.44 | 212,936,048.00 | -12.35% | 3,569,414.00 | 2015-04-15 | 43455615 | 2017438 | 2 | bvf-racapital | -7.69% | Decreased |
| 45 | GRAL | 2025-03-31 | GRAIL, Inc. | 23.26 | 788,402,368.00 | 25.26% | 22,501,359.00 | 2024-06-12 | 41921995 | 1641425 | 2 | baker-tang | -10.31% | Decreased |
| 46 | RAPT | 2025-03-31 | RAPT Therapeutics, Inc. | 0.79 | 104,351,528.00 | -34.13% | 58,439,423.00 | 2019-10-31 | 40019834 | 32803143 | 4 | bvf-deeptrack-perceptive-orbimed | -4.82% | Decreased |
| 47 | ENGN | 2025-03-31 | enGene Holdings Inc. | 4.00 | 203,910,400.00 | -50.37% | 24,461,582.00 | 2022-02-01 | 34822082 | 7772786 | 3 | cormorant-deeptrack-orbimed | -21.55% | Decreased |
| 48 | THRD | 2025-03-31 | Third Harmonic Bio, Inc. | 3.64 | 164,178,208.00 | -44.17% | 13,024,653.00 | 2022-09-14 | 31513607 | 9081731 | 3 | bvf-orbimed-tang | -27.03% | Decreased |
| 49 | DSGN | 2025-03-31 | Design Therapeutics, Inc. | 2.89 | 164,044,208.00 | -29.60% | 25,381,999.00 | 2021-03-29 | 29499383 | 7642327 | 3 | baker-logos-tang | -2.88% | Decreased |
| 50 | FULC | 2025-03-31 | Fulcrum Therapeutics, Inc. | 3.29 | 177,591,888.00 | -17.75% | 26,503,299.00 | 2019-07-18 | 29459805 | 10229099 | 1 | racapital | -2.27% | Decreased |
| 51 | LEGN | 2025-03-31 | Legend Biotech Corporation | 32.80 | 6,023,686,656.00 | -5.39% | 161,989,576.00 | 2020-06-05 | 28161900 | 830000 | 1 | tang | -89.57% | Decreased |
| 52 | ACRV | 2025-03-31 | Acrivon Therapeutics, Inc. | 1.62 | 50,789,432.00 | -70.60% | 11,274,619.00 | 2022-11-15 | 27860075 | 13724175 | 3 | baker-perceptive-racapital | -0.22% | Decreased |
| 53 | CERS | 2025-03-31 | Cerus Corporation | 1.30 | 241,526,992.00 | -29.73% | 158,448,986.00 | 1997-01-31 | 26898011 | 19351087 | 1 | baker | -0.65% | Decreased |
| 54 | TGTX | 2025-03-31 | TG Therapeutics, Inc. | 38.32 | 6,018,960,896.00 | 28.33% | 134,539,735.00 | 2010-05-03 | 25038050 | 635000 | 2 | opaleye-tang | -73.09% | Decreased |
| 55 | TARA | 2025-03-31 | Protara Therapeutics, Inc. | 3.90 | 143,393,248.00 | -18.07% | 30,107,039.00 | 2014-10-22 | 24140704 | 5666832 | 3 | baker-racapital-opaleye | -1.65% | Decreased |
| 56 | ARVN | 2025-03-31 | Arvinas, Inc. | 8.60 | 591,438,400.00 | -53.69% | 53,685,383.00 | 2018-09-27 | 23648976 | 3368800 | 2 | opaleye-tang | -68.28% | Decreased |
| 57 | ALMS | 2025-03-31 | Alumis Inc. | 6.48 | 352,559,296.00 | -10.00% | 4,764,450.00 | 2024-06-28 | 22778761 | 3709896 | 2 | baker-cormorant | -13.92% | Decreased |
| 58 | GILD | 2025-03-31 | Gilead Sciences, Inc. | 104.54 | 130,322,702,336.00 | 12.46% | 1,242,681,021.00 | 1992-01-22 | 22129875 | 197500 | 1 | orbimed | -19.58% | Decreased |
| 59 | VIR | 2025-03-31 | Vir Biotechnology, Inc. | 6.12 | 868,421,888.00 | -40.47% | 92,043,716.00 | 2019-10-11 | 21324307 | 3290788 | 3 | baker-orbimed-tang | -23.53% | Decreased |
| 60 | ARQT | 2025-03-31 | Arcutis Biotherapeutics, Inc. | 13.01 | 1,543,480,448.00 | -0.54% | 85,242,758.00 | 2020-01-31 | 21114000 | 1350000 | 1 | cormorant | -26.03% | Decreased |
| 61 | TVTX | 2025-03-31 | Travere Therapeutics, Inc. | 14.50 | 1,287,189,632.00 | -22.00% | 75,506,943.00 | 2012-11-08 | 20608000 | 1150000 | 1 | racapital | -46.51% | Decreased |
| 62 | CRBP | 2025-03-31 | Corbus Pharmaceuticals Holdings | 6.03 | 73,760,168.00 | -49.46% | 7,526,368.00 | 2014-10-27 | 19513225 | 3674807 | 3 | cormorant-orbimed-tang | -3.04% | Decreased |
| 63 | FHTX | 2025-03-31 | Foghorn Therapeutics Inc. | 3.45 | 191,862,096.00 | -21.05% | 25,845,788.00 | 2020-10-23 | 19352300 | 5302000 | 1 | bvf | -0.84% | Decreased |
| 64 | VKTX | 2025-03-31 | Viking Therapeutics, Inc. | 24.99 | 2,881,321,984.00 | -25.31% | 109,861,197.00 | 2015-04-28 | 18812971 | 779005 | 2 | perceptive-tang | -40.80% | Decreased |
| 65 | PODD | 2025-03-31 | Insulet Corporation | 253.99 | 17,836,726,272.00 | -5.22% | 69,910,789.00 | 2007-05-15 | 18802088 | 71597 | 1 | perceptive | -69.17% | Decreased |
| 66 | CBLL | 2025-03-31 | CeriBell, Inc. | 15.00 | 538,024,512.00 | -28.02% | 21,912,327.00 | 2024-10-11 | 18001345 | 937082 | 2 | racapital-orbimed | -16.15% | Decreased |
| 67 | TXG | 2025-03-31 | 10x Genomics, Inc. | 8.30 | 1,023,240,640.00 | -44.11% | 106,469,868.00 | 2019-09-12 | 16973276 | 1944247 | 1 | racapital | -40.71% | Decreased |
| 68 | MNMD | 2025-03-31 | Mind Medicine (MindMed) Inc. | 5.43 | 409,250,400.00 | -16.40% | 70,224,468.00 | 2016-11-15 | 16966170 | 2900200 | 2 | deeptrack-tang | -3.86% | Decreased |
| 69 | AGIO | 2025-03-31 | Agios Pharmaceuticals, Inc. | 27.66 | 1,584,812,928.00 | -16.76% | 50,708,827.00 | 2013-07-24 | 16862150 | 575500 | 2 | casdin-orbimed | -57.38% | Decreased |
| 70 | PEPG | 2025-03-31 | PepGen Inc. | 1.13 | 36,942,412.00 | -59.64% | 10,471,699.00 | 2022-05-06 | 15608911 | 11109545 | 2 | racapital-opaleye | -9.55% | Decreased |
| 71 | TNGX | 2025-03-31 | Tango Therapeutics, Inc. | 1.41 | 152,432,272.00 | -50.70% | 46,645,311.00 | 2020-09-03 | 15488858 | 11305736 | 3 | casdin-ecor1-orbimed | -8.60% | Decreased |
| 72 | DNA | 2025-03-31 | Ginkgo Bioworks Holdings, Inc. | 8.12 | 471,232,832.00 | -8.35% | 36,712,127.00 | 2021-04-19 | 15354780 | 2693821 | 3 | casdin-ecor1-opaleye | -9.60% | Decreased |
| 73 | TRVI | 2025-03-31 | Trevi Therapeutics, Inc. | 6.47 | 625,533,824.00 | 62.97% | 73,666,058.00 | 2019-05-07 | 14716807 | 2339715 | 3 | logos-orbimed-opaleye | -34.42% | Decreased |
| 74 | AVIR | 2025-03-31 | Atea Pharmaceuticals, Inc. | 2.71 | 231,773,296.00 | -15.31% | 66,621,549.00 | 2020-10-30 | 14352000 | 4800000 | 1 | tang | -40.96% | Decreased |
| 75 | RCKT | 2025-03-31 | Rocket Pharmaceuticals, Inc. | 6.33 | 674,967,872.00 | -37.70% | 80,783,728.00 | 2015-02-18 | 13925659 | 2087805 | 3 | baker-perceptive-tang | -13.93% | Decreased |
| 76 | CADL | 2025-03-31 | Candel Therapeutics, Inc. | 4.97 | 234,760,432.00 | -36.04% | 35,925,874.00 | 2021-07-27 | 13770118 | 2437189 | 1 | baker | -18.27% | Decreased |
| 77 | NVAX | 2025-03-31 | Novavax, Inc. | 6.00 | 965,064,000.00 | -31.90% | 135,577,182.00 | 1995-12-05 | 13577547 | 2118182 | 2 | deeptrack-tang | -18.53% | Decreased |
| 78 | CTNM | 2025-03-31 | Contineum Therapeutics, Inc. | 4.01 | 103,745,120.00 | -69.69% | 13,299,011.00 | 2024-04-05 | 13276532 | 1902082 | 3 | baker-casdin-perceptive | -7.23% | Decreased |
| 79 | CCCC | 2025-03-31 | C4 Therapeutics, Inc. | 1.24 | 88,027,224.00 | -64.57% | 47,230,841.00 | 2020-10-02 | 12368480 | 7730300 | 2 | orbimed-tang | -23.88% | Decreased |
| 80 | TCRX | 2025-03-31 | TScan Therapeutics, Inc. | 1.24 | 70,172,344.00 | -54.41% | 37,137,033.00 | 2021-07-16 | 12333197 | 8937099 | 4 | baker-bvf-ecor1-tang | -17.95% | Decreased |
| 81 | SNDX | 2025-03-31 | Syndax Pharmaceuticals, Inc. | 11.54 | 992,947,776.00 | -15.58% | 76,941,078.00 | 2016-03-02 | 10257975 | 835000 | 2 | casdin-tang | -70.70% | Decreased |
| 82 | HRMY | 2025-03-31 | Harmony Biosciences Holdings, I | 29.17 | 1,673,970,048.00 | -19.97% | 44,329,878.00 | 2020-08-19 | 9333028 | 281200 | 1 | tang | -83.76% | Decreased |
| 83 | FBRX | 2025-03-31 | Forte Biosciences, Inc. | 7.34 | 48,309,460.00 | -50.07% | 3,572,266.00 | 2017-04-13 | 9213991 | 1187370 | 2 | bvf-orbimed | -7.96% | Decreased |
| 84 | BMEA | 2025-03-31 | Biomea Fusion, Inc. | 1.75 | 65,751,524.00 | -57.83% | 29,397,656.00 | 2021-04-16 | 7605957 | 3570872 | 1 | cormorant | -28.91% | Decreased |
| 85 | PMVP | 2025-03-31 | PMV Pharmaceuticals, Inc. | 0.87 | 45,286,100.00 | -37.27% | 34,407,051.00 | 2020-09-25 | 7058067 | 6475291 | 1 | orbimed | -4.74% | Decreased |
| 86 | IBRX | 2025-03-31 | ImmunityBio, Inc. | 2.63 | 2,320,888,320.00 | 6.05% | 204,851,716.00 | 2015-07-28 | 7023332 | 2333333 | 1 | tang | -66.84% | Decreased |
| 87 | IVVD | 2025-03-31 | Invivyd, Inc. | 0.55 | 65,858,592.00 | 37.59% | 47,996,574.00 | 2021-08-06 | 6692048 | 11055754 | 3 | deeptrack-orbimed-tang | -9.15% | Decreased |
| 88 | FATE | 2025-03-31 | Fate Therapeutics, Inc. | 1.11 | 127,202,672.00 | -15.91% | 99,964,480.00 | 2013-10-01 | 5378016 | 6806755 | 3 | baker-orbimed-tang | -30.86% | Decreased |
| 89 | BIIB | 2025-03-31 | Biogen Inc. | 118.61 | 17,361,539,072.00 | -15.87% | 146,001,681.00 | 1991-09-17 | 4789400 | 35000 | 1 | tang | -93.57% | Decreased |
| 90 | GOSS | 2025-03-31 | Gossamer Bio, Inc. | 0.84 | 191,433,680.00 | -8.62% | 183,672,034.00 | 2019-02-08 | 4716157 | 4287415 | 1 | opaleye | -4.51% | Decreased |
| 91 | GMAB | 2025-03-31 | Genmab A/S | 20.04 | 12,541,773,824.00 | -8.07% | 62,846,320.00 | 2009-06-01 | 3916000 | 200000 | 1 | tang | -90.48% | Decreased |
| 92 | VTYX | 2025-03-31 | Ventyx Biosciences, Inc. | 0.97 | 68,889,496.00 | -50.33% | 54,957,214.00 | 2021-10-21 | 3783500 | 3290000 | 2 | opaleye-tang | -2.66% | Decreased |
| 93 | BHVN | 2025-03-31 | Biohaven Ltd. | 20.37 | 2,079,064,192.00 | -47.81% | 84,648,084.00 | 2022-09-23 | 3606000 | 150000 | 2 | cormorant-tang | -23.29% | Decreased |
| 94 | SANA | 2025-03-31 | Sana Biotechnology, Inc. | 1.76 | 396,043,968.00 | -49.13% | 134,123,841.00 | 2021-02-04 | 3411994 | 2030949 | 1 | baker | -14.70% | Decreased |
| 95 | BDSX | 2025-03-31 | Biodesix, Inc. | 0.53 | 77,368,336.00 | -57.26% | 66,204,129.00 | 2020-10-28 | 3374945 | 5398880 | 2 | perceptive-opaleye | -4.26% | Decreased |
| 96 | PASG | 2025-03-31 | Passage Bio, Inc. | 0.33 | 20,508,940.00 | -46.52% | 48,820,577.00 | 2020-02-28 | 3013576 | 8534626 | 2 | orbimed-tang | -4.16% | Decreased |
| 97 | NMRA | 2025-03-31 | Neumora Therapeutics, Inc. | 0.68 | 110,437,288.00 | -71.83% | 85,270,564.00 | 2023-09-14 | 2434600 | 2434600 | 2 | baker-tang | -69.23% | Decreased |
| 98 | LXEO | 2025-03-31 | Lexeo Therapeutics, Inc. | 1.98 | 65,730,060.00 | -68.77% | 21,795,488.00 | 2023-11-03 | 2381769 | 686389 | 2 | perceptive-racapital | -15.92% | Decreased |
| 99 | SEER | 2025-03-31 | Seer, Inc. | 2.00 | 119,564,000.00 | -13.79% | 41,961,608.00 | 2020-12-04 | 2187575 | 1294423 | 1 | tang | -41.01% | Decreased |
| 100 | IPSC | 2025-03-31 | Century Therapeutics, Inc. | 0.48 | 41,301,600.00 | -50.52% | 39,812,176.00 | 2021-06-18 | 2072504 | 4354000 | 3 | baker-casdin-tang | -36.79% | Decreased |
| 101 | ATYR | 2025-03-31 | aTyr Pharma, Inc. | 2.97 | 263,910,048.00 | -9.73% | 81,953,409.00 | 2015-05-07 | 2026825 | 671134 | 1 | tang | -59.84% | Decreased |
| 102 | MREO | 2025-03-31 | Mereo BioPharma Group plc | 1.95 | 310,050,016.00 | -41.62% | 486,079,784.00 | 2019-04-24 | 1973162 | 876961 | 1 | perceptive | -19.21% | Decreased |
| 103 | ALXO | 2025-03-31 | ALX Oncology Holdings Inc. | 0.55 | 29,361,256.00 | -66.67% | 32,339,047.00 | 2020-07-17 | 1967599 | 3158265 | 1 | tang | -4.20% | Decreased |
| 104 | CRDF | 2025-03-31 | Cardiff Oncology, Inc. | 2.85 | 189,594,256.00 | -19.03% | 59,796,027.00 | 2004-07-27 | 1801996 | 573884 | 1 | orbimed | -62.70% | Decreased |
| 105 | ELEV | 2025-03-31 | Elevation Oncology, Inc. | 0.28 | 16,580,424.00 | -61.17% | 37,016,978.00 | 2021-06-25 | 1233316 | 4760000 | 1 | tang | -45.09% | Decreased |
| 106 | HOOK | 2025-03-31 | HOOKIPA Pharma Inc. | 0.77 | 9,325,225.00 | -62.09% | 9,536,526.00 | 2019-04-18 | 877839 | 812814 | 1 | baker | -32.36% | Decreased |
| 107 | RXRX | 2025-03-31 | Recursion Pharmaceuticals, Inc. | 5.76 | 2,315,468,288.00 | -14.54% | 382,695,117.00 | 2021-04-16 | 874559 | 165323 | 1 | casdin | -97.90% | Decreased |
| 108 | OPRX | 2025-03-31 | OptimizeRx Corporation | 8.13 | 150,326,960.00 | 67.63% | 14,276,611.00 | 2007-11-28 | 866000 | 100000 | 1 | tang | -54.79% | Decreased |
| 109 | PACB | 2025-03-31 | Pacific Biosciences of Californ | 1.17 | 348,486,816.00 | -31.18% | 295,618,336.00 | 2010-10-27 | 854045 | 723767 | 1 | casdin | -30.13% | Decreased |
| 110 | GBIO | 2025-03-31 | Generation Bio Co. | 0.39 | 26,273,798.00 | -60.39% | 48,781,725.00 | 2020-06-12 | 787703 | 1944945 | 1 | baker | -51.28% | Decreased |
| 111 | FTRE | 2025-03-31 | Fortrea Holdings Inc. | 5.18 | 467,236,000.00 | -71.71% | 78,282,776.00 | 2023-06-20 | 755000 | 100000 | 1 | tang | -73.33% | Decreased |
| 112 | NXTC | 2025-03-31 | NextCure, Inc. | 0.36 | 10,116,020.00 | -55.30% | 21,067,748.00 | 2019-05-09 | 742228 | 1545344 | 2 | orbimed-tang | -16.07% | Decreased |
| 113 | ENTA | 2025-03-31 | Enanta Pharmaceuticals, Inc. | 5.10 | 108,795,744.00 | -0.39% | 14,292,378.00 | 2013-03-21 | 699136 | 126655 | 1 | tang | -89.13% | Decreased |
| 114 | NBTX | 2025-03-31 | Nanobiotix S.A. | 3.33 | 157,952,464.00 | 14.90% | 25,528,397.00 | 2020-12-11 | 376090 | 105053 | 1 | perceptive | -60.52% | Decreased |
| 115 | LPTX | 2025-03-31 | Leap Therapeutics, Inc. | 0.36 | 14,993,012.00 | -85.23% | 31,782,794.00 | 2017-01-25 | 123487 | 404744 | 1 | baker | -65.47% | Decreased |
| 116 | OPT | 2025-03-31 | Opthea Limited | 3.41 | 524,819,488.00 | -4.62% | 785,981,303.00 | 2020-10-16 | 0 | 2087320 | 1 | baker | -3.97% | Decreased |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) Sorted by Decrease in Share %
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | RXRX | 2025-03-31 | Recursion Pharmaceuticals, Inc. | 5.76 | 2,315,468,288.00 | -14.54% | 382,695,117.00 | 2021-04-16 | 874559 | 165323 | 1 | casdin | -97.90% |
| 1 | BIIB | 2025-03-31 | Biogen Inc. | 118.61 | 17,361,539,072.00 | -15.87% | 146,001,681.00 | 1991-09-17 | 4789400 | 35000 | 1 | tang | -93.57% |
| 2 | GMAB | 2025-03-31 | Genmab A/S | 20.04 | 12,541,773,824.00 | -8.07% | 62,846,320.00 | 2009-06-01 | 3916000 | 200000 | 1 | tang | -90.48% |
| 3 | LEGN | 2025-03-31 | Legend Biotech Corporation | 32.80 | 6,023,686,656.00 | -5.39% | 161,989,576.00 | 2020-06-05 | 28161900 | 830000 | 1 | tang | -89.57% |
| 4 | ENTA | 2025-03-31 | Enanta Pharmaceuticals, Inc. | 5.10 | 108,795,744.00 | -0.39% | 14,292,378.00 | 2013-03-21 | 699136 | 126655 | 1 | tang | -89.13% |
| 5 | SWTX | 2025-03-31 | SpringWorks Therapeutics, Inc. | 37.92 | 2,843,408,384.00 | 4.32% | 73,786,642.00 | 2019-09-13 | 45209640 | 1024465 | 2 | orbimed-tang | -83.87% |
| 6 | HRMY | 2025-03-31 | Harmony Biosciences Holdings, I | 29.17 | 1,673,970,048.00 | -19.97% | 44,329,878.00 | 2020-08-19 | 9333028 | 281200 | 1 | tang | -83.76% |
| 7 | FTRE | 2025-03-31 | Fortrea Holdings Inc. | 5.18 | 467,236,000.00 | -71.71% | 78,282,776.00 | 2023-06-20 | 755000 | 100000 | 1 | tang | -73.33% |
| 8 | TGTX | 2025-03-31 | TG Therapeutics, Inc. | 38.32 | 6,018,960,896.00 | 28.33% | 134,539,735.00 | 2010-05-03 | 25038050 | 635000 | 2 | opaleye-tang | -73.09% |
| 9 | SNDX | 2025-03-31 | Syndax Pharmaceuticals, Inc. | 11.54 | 992,947,776.00 | -15.58% | 76,941,078.00 | 2016-03-02 | 10257975 | 835000 | 2 | casdin-tang | -70.70% |
| 10 | NMRA | 2025-03-31 | Neumora Therapeutics, Inc. | 0.68 | 110,437,288.00 | -71.83% | 85,270,564.00 | 2023-09-14 | 2434600 | 2434600 | 2 | baker-tang | -69.23% |
| 11 | PODD | 2025-03-31 | Insulet Corporation | 253.99 | 17,836,726,272.00 | -5.22% | 69,910,789.00 | 2007-05-15 | 18802088 | 71597 | 1 | perceptive | -69.17% |
| 12 | ARVN | 2025-03-31 | Arvinas, Inc. | 8.60 | 591,438,400.00 | -53.69% | 53,685,383.00 | 2018-09-27 | 23648976 | 3368800 | 2 | opaleye-tang | -68.28% |
| 13 | IBRX | 2025-03-31 | ImmunityBio, Inc. | 2.63 | 2,320,888,320.00 | 6.05% | 204,851,716.00 | 2015-07-28 | 7023332 | 2333333 | 1 | tang | -66.84% |
| 14 | LPTX | 2025-03-31 | Leap Therapeutics, Inc. | 0.36 | 14,993,012.00 | -85.23% | 31,782,794.00 | 2017-01-25 | 123487 | 404744 | 1 | baker | -65.47% |
| 15 | CRDF | 2025-03-31 | Cardiff Oncology, Inc. | 2.85 | 189,594,256.00 | -19.03% | 59,796,027.00 | 2004-07-27 | 1801996 | 573884 | 1 | orbimed | -62.70% |
| 16 | NBTX | 2025-03-31 | Nanobiotix S.A. | 3.33 | 157,952,464.00 | 14.90% | 25,528,397.00 | 2020-12-11 | 376090 | 105053 | 1 | perceptive | -60.52% |
| 17 | ATYR | 2025-03-31 | aTyr Pharma, Inc. | 2.97 | 263,910,048.00 | -9.73% | 81,953,409.00 | 2015-05-07 | 2026825 | 671134 | 1 | tang | -59.84% |
| 18 | AGIO | 2025-03-31 | Agios Pharmaceuticals, Inc. | 27.66 | 1,584,812,928.00 | -16.76% | 50,708,827.00 | 2013-07-24 | 16862150 | 575500 | 2 | casdin-orbimed | -57.38% |
| 19 | OPRX | 2025-03-31 | OptimizeRx Corporation | 8.13 | 150,326,960.00 | 67.63% | 14,276,611.00 | 2007-11-28 | 866000 | 100000 | 1 | tang | -54.79% |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) with the Highest Fund Number
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | RYTM | 2025-03-31 | Rhythm Pharmaceuticals, Inc. | 61.74 | 3,903,431,424.00 | 7.34% | 46,955,630.00 | 2017-10-09 | 808181301 | 15257340 | 6 | baker-cormorant-perceptive-racapital-orbimed-opaleye | -11.03% |
| 1 | CNTA | 2025-03-31 | Centessa Pharmaceuticals plc | 11.57 | 1,540,938,880.00 | -24.18% | 93,006,626.00 | 2021-05-28 | 152847508 | 10629173 | 5 | avoro-baker-cormorant-perceptive-tang | -7.48% |
| 2 | OCUL | 2025-03-31 | Ocular Therapeutix, Inc. | 7.31 | 1,162,450,816.00 | -9.64% | 124,121,633.00 | 2014-07-25 | 199120880 | 27165195 | 5 | avoro-deeptrack-logos-perceptive-opaleye | -8.89% |
| 3 | ARGX | 2025-03-31 | argenx SE | 596.20 | 36,474,028,032.00 | -7.91% | 60,989,637.00 | 2017-05-18 | 934641839 | 1579147 | 4 | avoro-baker-perceptive-orbimed | -1.77% |
| 4 | CRNX | 2025-03-31 | Crinetics Pharmaceuticals, Inc. | 30.42 | 2,830,535,168.00 | -21.52% | 91,642,575.00 | 2018-07-18 | 209193005 | 6237120 | 4 | cormorant-ecor1-logos-orbimed | -3.62% |
| 5 | TCRX | 2025-03-31 | TScan Therapeutics, Inc. | 1.24 | 70,172,344.00 | -54.41% | 37,137,033.00 | 2021-07-16 | 12333197 | 8937099 | 4 | baker-bvf-ecor1-tang | -17.95% |
| 6 | VERV | 2025-03-31 | Verve Therapeutics, Inc. | 3.26 | 289,474,304.00 | -40.73% | 64,970,975.00 | 2021-06-17 | 63254060 | 13841151 | 4 | baker-bvf-casdin-ecor1 | -2.47% |
| 7 | IMTX | 2025-03-31 | Immatics N.V. | 4.26 | 517,803,040.00 | -21.11% | 61,326,922.00 | 2018-12-12 | 96950334 | 21496748 | 4 | baker-perceptive-racapital-orbimed | -0.76% |
| 8 | BCYC | 2025-03-31 | Bicycle Therapeutics plc | 7.39 | 511,405,728.00 | -45.50% | NaN | 2019-05-23 | 115938167 | 13655850 | 4 | baker-deeptrack-ecor1-racapital | -4.92% |
| 9 | RAPT | 2025-03-31 | RAPT Therapeutics, Inc. | 0.79 | 104,351,528.00 | -34.13% | 58,439,423.00 | 2019-10-31 | 40019834 | 32803143 | 4 | bvf-deeptrack-perceptive-orbimed | -4.82% |
| 10 | AXSM | 2025-03-31 | Axsome Therapeutics, Inc. | 104.46 | 5,094,033,408.00 | 8.61% | 36,674,021.00 | 2015-11-19 | 312804925 | 2682028 | 4 | bvf-cormorant-perceptive-orbimed | -20.58% |
| 11 | SLNO | 2025-03-31 | Soleno Therapeutics, Inc. | 69.98 | 3,209,093,888.00 | 42.32% | 31,320,071.00 | 2014-11-13 | 309492963 | 4331602 | 4 | avoro-logos-perceptive-tang | -2.13% |
| 12 | TARA | 2025-03-31 | Protara Therapeutics, Inc. | 3.90 | 143,393,248.00 | -18.07% | 30,107,039.00 | 2014-10-22 | 24140704 | 5666832 | 3 | baker-racapital-opaleye | -1.65% |
| 13 | CRSP | 2025-03-31 | CRISPR Therapeutics AG | 37.77 | 3,261,938,176.00 | -9.01% | 85,368,761.00 | 2016-10-19 | 78605046 | 2309875 | 3 | baker-ecor1-tang | -22.06% |
| 14 | ABCL | 2025-03-31 | AbCellera Biologics Inc. | 2.40 | 715,171,200.00 | -20.00% | 202,801,468.00 | 2020-12-11 | 76503290 | 34306408 | 3 | baker-orbimed-tang | -2.69% |
| 15 | THRD | 2025-03-31 | Third Harmonic Bio, Inc. | 3.64 | 164,178,208.00 | -44.17% | 13,024,653.00 | 2022-09-14 | 31513607 | 9081731 | 3 | bvf-orbimed-tang | -27.03% |
| 16 | ENGN | 2025-03-31 | enGene Holdings Inc. | 4.00 | 203,910,400.00 | -50.37% | 24,461,582.00 | 2022-02-01 | 34822082 | 7772786 | 3 | cormorant-deeptrack-orbimed | -21.55% |
| 17 | ACLX | 2025-03-31 | Arcellx, Inc. | 59.15 | 3,249,937,664.00 | -12.19% | 32,601,579.00 | 2022-02-04 | 460053128 | 7013005 | 3 | cormorant-perceptive-racapital | -7.31% |
| 18 | CTNM | 2025-03-31 | Contineum Therapeutics, Inc. | 4.01 | 103,745,120.00 | -69.69% | 13,299,011.00 | 2024-04-05 | 13276532 | 1902082 | 3 | baker-casdin-perceptive | -7.23% |
| 19 | DRUG | 2025-03-31 | Bright Minds Biosciences Inc. | 28.83 | 203,078,224.00 | -18.58% | 2,524,284.00 | 2021-03-22 | 61694380 | 1710407 | 3 | cormorant-perceptive-racapital | -21.14% |
------------------------------------------------------------ ------------------------------------------------------------ Unchanged Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ACAD | 2025-03-31 | ACADIA Pharmaceuticals Inc. | 14.73 | 2,456,801,792.00 | -17.66% | 114,380,229.00 | 2004-05-27 | 737117185 | 44377916 | 2 | baker-tang |
| 1 | SMMT | 2025-03-31 | Summit Therapeutics Inc. | 24.61 | 18,154,305,536.00 | 11.36% | 111,183,085.00 | 2015-03-05 | 471155646 | 24424865 | 1 | baker |
| 2 | WGS | 2025-03-31 | GeneDx Holdings Corp. | 96.63 | 2,712,239,872.00 | 13.67% | 18,444,224.00 | 2020-11-04 | 310611980 | 3507164 | 1 | casdin |
| 3 | LLY | 2025-03-31 | Eli Lilly and Company | 839.96 | 754,274,861,056.00 | 13.15% | 895,933,556.00 | 1972-06-01 | 278827216 | 337600 | 1 | orbimed |
| 4 | BLFS | 2025-03-31 | BioLife Solutions, Inc. | 21.91 | 1,041,785,408.00 | -20.27% | 36,395,390.00 | 1989-11-22 | 198871649 | 8707165 | 1 | casdin |
| 5 | WVE | 2025-03-31 | Wave Life Sciences Ltd. | 6.73 | 1,042,167,424.00 | -44.84% | 70,126,228.00 | 2015-11-11 | 149852262 | 18546072 | 2 | baker-racapital |
| 6 | PRTA | 2025-03-31 | Prothena Corporation plc | 9.20 | 495,208,384.00 | -34.80% | 32,018,442.00 | 2012-12-18 | 143355465 | 11584280 | 1 | ecor1 |
| 7 | ARWR | 2025-03-31 | Arrowhead Pharmaceuticals, Inc. | 11.24 | 1,543,442,944.00 | -43.12% | 108,000,510.00 | 1993-12-16 | 141555554 | 11111111 | 1 | avoro |
| 8 | BCAX | 2025-03-31 | Bicara Therapeutics Inc. | 10.77 | 587,215,936.00 | -17.09% | 28,372,303.00 | 2024-09-13 | 131441780 | 10087627 | 4 | baker-deeptrack-racapital-orbimed |
| 9 | LENZ | 2025-03-31 | LENZ Therapeutics, Inc. | 20.26 | 558,023,232.00 | -12.67% | 11,210,776.00 | 2021-06-25 | 127155566 | 4945763 | 2 | racapital-tang |
| 10 | RXST | 2025-03-31 | RxSight, Inc. | 14.08 | 570,106,240.00 | -54.17% | 32,215,490.00 | 2021-07-30 | 94511205 | 3743018 | 1 | racapital |
| 11 | MGTX | 2025-03-31 | MeiraGTx Holdings plc | 5.41 | 426,604,960.00 | -15.60% | 31,284,119.00 | 2018-06-08 | 85254892 | 12581103 | 1 | perceptive |
| 12 | EYPT | 2025-03-31 | EyePoint Pharmaceuticals, Inc. | 5.67 | 390,035,968.00 | -25.62% | 43,542,419.00 | 2005-01-27 | 70698979 | 13044092 | 3 | cormorant-perceptive-racapital |
| 13 | AORT | 2025-03-31 | Artivion, Inc. | 23.37 | 997,648,960.00 | -20.35% | 36,399,595.00 | 1993-02-12 | 68669220 | 2793703 | 1 | perceptive |
| 14 | ATXS | 2025-03-31 | Astria Therapeutics, Inc. | 4.04 | 227,994,160.00 | -45.84% | 33,969,449.00 | 2015-06-25 | 65097979 | 12190633 | 4 | logos-perceptive-racapital-tang |
| 15 | DNLI | 2025-03-31 | Denali Therapeutics Inc. | 12.74 | 1,850,039,168.00 | -44.70% | 131,342,965.00 | 2017-12-08 | 64191444 | 4721695 | 2 | baker-casdin |
| 16 | ALDX | 2025-03-31 | Aldeyra Therapeutics, Inc. | 2.19 | 130,762,056.00 | -55.21% | 47,818,870.00 | 2014-05-02 | 53336143 | 9275851 | 1 | perceptive |
| 17 | DAWN | 2025-03-31 | Day One Biopharmaceuticals, Inc | 7.12 | 721,647,616.00 | -38.41% | 71,972,855.00 | 2021-05-27 | 52477925 | 6617645 | 2 | ecor1-racapital |
| 18 | TSHA | 2025-03-31 | Taysha Gene Therapies, Inc. | 1.25 | 255,227,488.00 | -25.45% | 127,701,667.00 | 2020-09-24 | 48479389 | 34877258 | 3 | avoro-baker-racapital |
| 19 | SIBN | 2025-03-31 | SI-BONE, Inc. | 13.85 | 587,975,424.00 | -19.90% | 37,756,528.00 | 2018-10-17 | 48303228 | 3442853 | 1 | orbimed |
| 20 | ZLAB | 2025-03-31 | Zai Lab Limited | 29.54 | 3,238,676,992.00 | 17.18% | 983,033,752.00 | 2017-09-20 | 46802746 | 1295040 | 1 | racapital |
| 21 | MNKD | 2025-03-31 | MannKind Corporation | 4.54 | 1,379,506,176.00 | -24.83% | 298,491,009.00 | 2004-07-28 | 44012500 | 8750000 | 1 | avoro |
| 22 | TRDA | 2025-03-31 | Entrada Therapeutics, Inc. | 7.90 | 296,997,344.00 | -40.91% | 19,019,077.00 | 2021-10-29 | 43987004 | 4865819 | 1 | baker |
| 23 | NPCE | 2025-03-31 | Neuropace, Inc. | 10.42 | 339,276,256.00 | -13.96% | 21,126,966.00 | 2021-04-22 | 41863857 | 3406335 | 1 | orbimed |
| 24 | ROIV | 2025-03-31 | Roivant Sciences Ltd. | 9.86 | 7,035,592,704.00 | -8.19% | 370,553,369.00 | 2020-12-08 | 38016830 | 3767773 | 1 | baker |
| 25 | TERN | 2025-03-31 | Terns Pharmaceuticals, Inc. | 2.14 | 186,816,880.00 | -55.42% | 53,712,485.00 | 2021-02-05 | 36265100 | 13139529 | 2 | deeptrack-orbimed |
| 26 | ABVX | 2025-03-31 | Abivax SA | 5.97 | 378,736,480.00 | -8.12% | 30,875,904.00 | 2023-10-20 | 35682556 | 5709209 | 2 | cormorant-deeptrack |
| 27 | XTNT | 2025-03-31 | Xtant Medical Holdings, Inc. | 0.41 | 56,600,676.00 | -18.60% | 37,064,381.00 | 2010-07-01 | 34363858 | 73114592 | 1 | orbimed |
| 28 | ELDN | 2025-03-31 | Eledon Pharmaceuticals, Inc. | 2.94 | 176,052,496.00 | -24.42% | 46,043,696.00 | 2014-09-17 | 33424112 | 9859620 | 2 | bvf-racapital |
| 29 | VOR | 2025-03-31 | Vor Biopharma Inc. | 0.70 | 87,396,400.00 | -48.91% | 38,992,387.00 | 2021-02-05 | 28446033 | 39646039 | 1 | racapital |
| 30 | EPIX | 2025-03-31 | ESSA Pharma Inc. | 1.79 | 79,455,592.00 | 2.87% | 28,160,984.00 | 2015-03-13 | 24108631 | 15258627 | 3 | bvf-opaleye-tang |
| 31 | PHVS | 2025-03-31 | Pharvaris N.V. | 12.00 | 653,917,184.00 | -26.87% | 19,413,727.00 | 2021-02-05 | 23023422 | 1466460 | 1 | cormorant |
| 32 | CRVS | 2025-03-31 | Corvus Pharmaceuticals, Inc. | 3.24 | 220,760,000.00 | -37.93% | 52,153,182.00 | 2016-03-23 | 22080820 | 6943654 | 1 | orbimed |
| 33 | OBIO | 2025-03-31 | Orchestra BioMed Holdings, Inc. | 2.98 | 114,171,248.00 | -41.91% | 18,386,175.00 | 2020-08-04 | 19656140 | 4592556 | 1 | perceptive |
| 34 | NTLA | 2025-03-31 | Intellia Therapeutics, Inc. | 7.23 | 748,427,904.00 | -27.26% | 97,913,025.00 | 2016-05-06 | 18799665 | 2644116 | 2 | baker-casdin |
| 35 | MNPR | 2025-03-31 | Monopar Therapeutics Inc. | 39.59 | 241,997,440.00 | 24.97% | 3,503,249.00 | 2019-12-19 | 18613047 | 511207 | 1 | racapital |
| 36 | SCPH | 2025-03-31 | scPharmaceuticals Inc. | 2.57 | 129,229,616.00 | -20.68% | 26,894,357.00 | 2017-11-17 | 17251559 | 6559528 | 2 | perceptive-orbimed |
| 37 | ABOS | 2025-03-31 | Acumen Pharmaceuticals, Inc. | 1.11 | 67,236,472.00 | -30.19% | 32,793,241.00 | 2021-07-01 | 16425269 | 14932063 | 1 | racapital |
| 38 | PRLD | 2025-03-31 | Prelude Therapeutics Incorporat | 0.71 | 39,060,488.00 | -31.24% | 16,835,400.00 | 2020-09-25 | 16153406 | 21033080 | 2 | baker-orbimed |
| 39 | GSK | 2025-03-31 | GSK plc | 34.64 | 70,245,416,960.00 | 5.93% | 3,947,946,444.00 | 1980-03-28 | 15496000 | 400000 | 1 | tang |
| 40 | SNY | 2025-03-31 | Sanofi | 50.90 | 126,228,955,136.00 | -1.53% | 1,129,611,427.00 | 2002-07-01 | 14974200 | 270000 | 1 | tang |
| 41 | INBX | 2025-03-31 | Inhibrx Biosciences, Inc. | 11.47 | 166,038,576.00 | -19.17% | 7,712,906.00 | 2024-06-04 | 14885723 | 1064026 | 1 | perceptive |
| 42 | ALT | 2025-03-31 | Altimmune, Inc. | 4.55 | 350,412,320.00 | -33.38% | 76,335,168.00 | 2017-05-26 | 13750000 | 2750000 | 1 | tang |
| 43 | RPTX | 2025-03-31 | Repare Therapeutics Inc. | 1.20 | 51,012,844.00 | -3.23% | 22,476,262.00 | 2020-06-19 | 13463537 | 13656088 | 2 | bvf-orbimed |
| 44 | VYGR | 2025-03-31 | Voyager Therapeutics, Inc. | 3.47 | 195,256,208.00 | -38.37% | 45,086,359.00 | 2015-11-11 | 13241305 | 3917546 | 1 | ecor1 |
| 45 | IKT | 2025-03-31 | Inhibikase Therapeutics, Inc. | 2.07 | 153,886,912.00 | -22.18% | 25,709,535.00 | 2020-12-23 | 12975750 | 5925000 | 1 | perceptive |
| 46 | ALEC | 2025-03-31 | Alector, Inc. | 0.92 | 91,168,936.00 | -46.82% | 73,332,475.00 | 2019-02-07 | 11925130 | 9695228 | 1 | racapital |
| 47 | NAUT | 2025-03-31 | Nautilus Biotechnology, Inc. | 0.79 | 99,783,072.00 | -57.01% | 46,630,782.00 | 2020-08-07 | 10843615 | 12594211 | 1 | perceptive |
| 48 | VNDA | 2025-03-31 | Vanda Pharmaceuticals Inc. | 4.25 | 251,342,032.00 | -4.49% | 51,637,107.00 | 2006-04-12 | 10801679 | 2353307 | 1 | tang |
| 49 | ACRS | 2025-03-31 | Aclaris Therapeutics, Inc. | 1.14 | 123,288,720.00 | -56.15% | 66,068,981.00 | 2015-10-06 | 10540001 | 6888889 | 2 | logos-racapital |
| 50 | DBVT | 2025-03-31 | DBV Technologies S.A. | 7.98 | 218,144,480.00 | 76.55% | 28,773,868.00 | 2014-10-22 | 9966919 | 1461425 | 1 | baker |
| 51 | IMUX | 2025-03-31 | Immunic, Inc. | 0.98 | 93,901,152.00 | 3.16% | 64,834,702.00 | 2014-04-17 | 9704239 | 8902972 | 1 | bvf |
| 52 | ADCT | 2025-03-31 | ADC Therapeutics SA | 1.21 | 119,891,400.00 | -31.25% | 73,042,624.00 | 2020-05-18 | 8415516 | 5968451 | 1 | orbimed |
| 53 | ZURA | 2025-03-31 | Zura Bio Limited | 1.21 | 82,733,752.00 | -39.20% | 46,618,074.00 | 2023-03-21 | 8386659 | 6501286 | 2 | deeptrack-racapital |
| 54 | VCYT | 2025-03-31 | Veracyte, Inc. | 31.80 | 2,478,644,480.00 | -25.67% | 77,565,181.00 | 2013-10-30 | 8192532 | 276308 | 1 | casdin |
| 55 | AVR | 2025-03-31 | Anteris Technologies Global Cor | 2.47 | 88,771,304.00 | -55.89% | 27,873,412.00 | 2024-12-13 | 7789600 | 2140000 | 1 | perceptive |
| 56 | HLVX | 2025-03-31 | HilleVax, Inc. | 1.67 | 83,735,632.00 | -16.50% | 30,028,884.00 | 2022-04-29 | 7134000 | 4920000 | 1 | tang |
| 57 | NUVB | 2025-03-31 | Nuvation Bio Inc. | 1.99 | 675,941,312.00 | -25.47% | 228,079,888.00 | 2020-08-26 | 6864000 | 3900000 | 1 | tang |
| 58 | HOWL | 2025-03-31 | Werewolf Therapeutics, Inc. | 0.71 | 31,827,312.00 | -47.41% | 26,381,231.00 | 2021-04-30 | 5974053 | 6144881 | 1 | racapital |
| 59 | NSPR | 2025-03-31 | InspireMD Inc. | 2.56 | 76,006,144.00 | -3.40% | 16,807,131.00 | 2011-04-12 | 5738859 | 2133405 | 1 | orbimed |
| 60 | MOLN | 2025-03-31 | Molecular Partners AG | 3.87 | 145,289,056.00 | -28.32% | 14,882,000.00 | 2021-06-16 | 5510650 | 1353968 | 1 | bvf |
| 61 | ADAP | 2025-03-31 | Adaptimmune Therapeutics plc | 0.24 | 61,272,660.00 | -58.21% | 1,054,028,457.00 | 2015-05-06 | 5398602 | 27404070 | 1 | ecor1 |
| 62 | INO | 2025-03-31 | Inovio Pharmaceuticals, Inc. | 1.74 | 63,811,892.00 | -20.91% | 33,103,900.00 | 1998-12-08 | 5084234 | 3119162 | 1 | deeptrack |
| 63 | LNTH | 2025-03-31 | Lantheus Holdings, Inc. | 101.32 | 6,951,696,384.00 | 7.73% | 61,829,554.00 | 2015-06-25 | 4880000 | 50000 | 1 | tang |
| 64 | CNTX | 2025-03-31 | Context Therapeutics Inc. | 0.78 | 69,978,248.00 | -24.26% | 40,555,266.00 | 2021-10-20 | 4540645 | 7419355 | 1 | deeptrack |
| 65 | KZR | 2025-03-31 | Kezar Life Sciences, Inc. | 4.16 | 30,392,126.00 | -34.28% | 4,911,032.00 | 2018-06-21 | 4453976 | 912700 | 2 | orbimed-tang |
| 66 | PRME | 2025-03-31 | Prime Medicine, Inc. | 1.33 | 174,444,128.00 | -51.99% | 60,638,823.00 | 2022-10-20 | 4170325 | 2095641 | 3 | baker-casdin-ecor1 |
| 67 | TNYA | 2025-03-31 | Tenaya Therapeutics, Inc. | 0.49 | 80,137,168.00 | -67.14% | 55,205,093.00 | 2021-07-30 | 3838467 | 6732971 | 1 | casdin |
| 68 | QTTB | 2025-03-31 | Q32 Bio Inc. | 2.08 | 25,371,008.00 | -32.90% | 5,426,353.00 | 2018-03-28 | 3717429 | 2252987 | 1 | orbimed |
| 69 | BOLD | 2025-03-31 | Boundless Bio, Inc. | 1.22 | 27,206,000.00 | -45.78% | 14,189,913.00 | 2024-03-28 | 3292753 | 2180631 | 1 | racapital |
| 70 | DTIL | 2025-03-31 | Precision BioSciences, Inc. | 5.02 | 52,961,500.00 | 10.09% | 8,756,605.00 | 2019-03-28 | 3211794 | 673332 | 1 | tang |
| 71 | BDTX | 2025-03-31 | Black Diamond Therapeutics, Inc | 1.44 | 81,593,568.00 | -35.71% | 38,983,042.00 | 2020-01-31 | 3208824 | 2070209 | 1 | tang |
| 72 | GLYC | 2025-03-31 | GlycoMimetics, Inc. | 0.22 | 14,386,600.00 | -14.23% | 42,802,367.00 | 2014-01-10 | 3138295 | 14944262 | 2 | bvf-logos |
| 73 | SGMT | 2025-03-31 | Sagimet Biosciences Inc. - Seri | 2.31 | 74,371,144.00 | -49.51% | 19,428,281.00 | 2023-07-17 | 3106767 | 952996 | 1 | baker |
| 74 | UNCY | 2025-03-31 | Unicycive Therapeutics, Inc. | 0.55 | 65,550,456.00 | -20.17% | 70,600,827.00 | 2021-07-12 | 2919875 | 5078927 | 1 | logos |
| 75 | ABSI | 2025-03-31 | Absci Corporation | 3.02 | 384,606,048.00 | 5.96% | 100,727,471.00 | 2021-07-22 | 2442883 | 973260 | 1 | casdin |
| 76 | TBPH | 2025-03-31 | Theravance Biopharma, Inc. | 8.62 | 431,011,200.00 | -5.79% | 21,119,514.00 | 2014-05-16 | 2347661 | 262896 | 1 | tang |
| 77 | SKYE | 2025-03-31 | Skye Bioscience, Inc. | 1.41 | 43,674,184.00 | -49.64% | 15,691,401.00 | 2015-01-06 | 2306514 | 1450638 | 1 | baker |
| 78 | TENX | 2025-03-31 | Tenax Therapeutics, Inc. | 5.32 | 21,095,822.00 | -17.52% | 3,915,154.00 | 1994-04-04 | 2224046 | 339549 | 1 | bvf |
| 79 | IDXX | 2025-03-31 | IDEXX Laboratories, Inc. | 411.49 | 33,346,738,176.00 | -3.71% | 80,436,876.00 | 1991-06-21 | 2099750 | 5000 | 1 | tang |
| 80 | IVA | 2025-03-31 | Inventiva S.A. - American Depos | 3.36 | 320,705,504.00 | 54.69% | 24,956,237.00 | 2020-07-10 | 2058120 | 686040 | 1 | bvf |
| 81 | TIL | 2025-03-31 | Instil Bio, Inc. | 15.03 | 98,084,128.00 | -20.98% | 2,670,001.00 | 2021-03-19 | 2027388 | 116785 | 1 | orbimed |
| 82 | CMMB | 2025-03-31 | Chemomab Therapeutics Ltd. | 1.07 | 20,114,334.00 | -46.13% | 236,378,933.00 | 2019-02-12 | 1897988 | 1741273 | 1 | orbimed |
| 83 | CDNA | 2025-03-31 | CareDx, Inc. | 18.81 | 1,042,561,152.00 | -24.97% | 54,071,844.00 | 2014-07-17 | 1775000 | 100000 | 1 | tang |
| 84 | ATHA | 2025-03-31 | Athira Pharma, Inc. | 0.25 | 9,760,600.00 | -52.92% | 27,560,062.00 | 2020-09-18 | 1710244 | 6002964 | 2 | perceptive-tang |
| 85 | VTVT | 2025-03-31 | vTv Therapeutics Inc. | 22.23 | 58,775,676.00 | 57.66% | 1,072,776.00 | 2015-07-30 | 1685478 | 97314 | 1 | baker |
| 86 | APLT | 2025-03-31 | Applied Therapeutics, Inc. | 0.33 | 47,144,808.00 | -49.16% | 103,058,488.00 | 2019-05-14 | 1607586 | 3288169 | 2 | perceptive-tang |
| 87 | LYRA | 2025-03-31 | Lyra Therapeutics, Inc. | 0.09 | 5,698,671.00 | -55.18% | 46,626,967.00 | 2020-05-01 | 1607453 | 12757562 | 1 | perceptive |
| 88 | BOLT | 2025-03-31 | Bolt Biotherapeutics, Inc. | 0.32 | 12,410,561.00 | -38.81% | 27,481,128.00 | 2021-02-05 | 1525109 | 3812773 | 1 | tang |
| 89 | IBIO | 2025-03-31 | iBio, Inc. | 0.89 | 8,961,293.00 | -69.52% | 8,599,460.00 | 2008-08-19 | 1507500 | 375000 | 1 | opaleye |
| 90 | RZLT | 2025-03-31 | Rezolute, Inc. | 2.75 | 166,472,352.00 | -44.11% | 52,813,526.00 | 2013-01-14 | 1348500 | 465000 | 1 | opaleye |
| 91 | TSBX | 2025-03-31 | Turnstone Biologics Corp. | 0.39 | 8,908,476.00 | -19.62% | 13,392,099.00 | 2023-07-21 | 1270699 | 3099265 | 1 | orbimed |
| 92 | SABS | 2025-03-31 | SAB Biotherapeutics, Inc. | 1.23 | 11,352,002.00 | -66.39% | 6,791,463.00 | 2021-02-09 | 1239065 | 917826 | 1 | bvf |
| 93 | OVID | 2025-03-31 | Ovid Therapeutics Inc. | 0.29 | 20,512,244.00 | -58.65% | 50,468,940.00 | 2017-05-05 | 1202006 | 3853818 | 1 | bvf |
| 94 | PHGE | 2025-03-31 | BiomX Inc. | 0.54 | 13,474,203.00 | -29.36% | 17,770,088.00 | 2019-03-13 | 993462 | 1787767 | 1 | orbimed |
| 95 | OABI | 2025-03-31 | OmniAb, Inc. | 1.93 | 235,720,544.00 | -42.22% | 99,520,435.00 | 2021-09-30 | 720000 | 300000 | 1 | tang |
| 96 | PBYI | 2025-03-31 | Puma Biotechnology Inc | 2.86 | 141,886,880.00 | -4.03% | 42,095,259.00 | 2012-04-24 | 592000 | 200000 | 1 | tang |
| 97 | ANRO | 2025-03-31 | Alto Neuroscience, Inc. | 2.13 | 57,663,576.00 | -49.88% | 19,503,574.00 | 2024-02-02 | 540000 | 250000 | 1 | orbimed |
| 98 | BCAB | 2025-03-31 | BioAtla, Inc. | 0.30 | 17,678,014.00 | -39.34% | 42,296,447.00 | 2020-12-16 | 476530 | 1374076 | 1 | tang |
| 99 | XERS | 2025-03-31 | Xeris Biopharma Holdings, Inc. | 4.16 | 640,390,400.00 | 26.83% | 146,657,227.00 | 2018-06-21 | 441506 | 80420 | 1 | orbimed |
| 100 | LSB | 2025-03-31 | LakeShore Biopharma Co., Ltd | 1.69 | 32,246,554.00 | -40.93% | 3,598,630.00 | 2021-08-05 | 344049 | 140428 | 1 | orbimed |
| 101 | MGNX | 2025-03-31 | MacroGenics, Inc. | 1.26 | 79,493,776.00 | -58.00% | 52,340,363.00 | 2013-10-10 | 277947 | 218856 | 1 | tang |
| 102 | ENSC | 2025-03-31 | Ensysce Biosciences, Inc. | 2.03 | 2,852,413.00 | -71.69% | 896,490.00 | 2018-03-14 | 221865 | 86666 | 1 | perceptive |
| 103 | NLSP | 2025-03-31 | NLS Pharmaceutics Ltd. | 1.35 | 5,476,437.00 | -34.78% | 457,622.00 | 2021-01-29 | 221261 | 143676 | 1 | bvf |
| 104 | APYX | 2025-03-31 | Apyx Medical Corporation | 0.96 | 36,206,556.00 | -35.70% | 29,121,701.00 | 2019-01-02 | 205500 | 150000 | 1 | perceptive |
| 105 | AFMD | 2025-03-31 | Affimed N.V. | 0.73 | 12,023,752.00 | -35.66% | 15,477,650.00 | 2014-09-12 | 107261 | 148315 | 1 | tang |
------------------------------------------------------------ ------------------------------------------------------------ 13F positions: New: ACHC,ADPT,AMGN,ANIK,AQST,BLUE,CAPR,DHAI,DXCM,GEHC,GKOS,HUMA,KMTS,MGX,OM,OPTN,QNCX,RCEL,RCUS,RGEN,SAGE,SAVA,SGMO,SNWV,STRO,TEVA Increased: ACET,ACIU,ADMA,AKRO,ALGS,ALLK,AMLX,ANAB,ANIP,ANNX,APLS,ASND,ATRA,AUPH,AUTL,AVDL,AVTX,AZN,BBIO,BEAM,BIOA,BLCO,BPMC,CDXS,CELC,CGEM,CGON,CHRS,CLDX,CMPS,CMPX,CRGX,CTMX,CYBN,DCTH,DERM,DNTH,DVAX,DYN,ELAN,ELVN,ERAS,ETNB,ETON,EW,EWTX,FDMT,GERN,GHRS,GLPG,GLUE,GPCR,HRTX,IDYA,IGMS,IKNA,IMCR,IMNM,IMVT,INCY,INSM,IONS,IRON,ITGR,ITOS,JANX,JNJ,KALA,KALV,KNSA,KOD,KRON,KROS,KRRO,KURA,KYMR,LAB,LQDA,LRMR,LXRX,MBX,MDGL,MLTX,MRNA,MRUS,NAMS,NGNE,NKTX,NRIX,NTRA,ORIC,OTLK,PCVX,PFE,PHAT,PLRX,PTCT,PTGX,PYXS,QURE,RAPP,RARE,REGN,REPL,RGLS,RLAY,RNA,RVMD,RVPH,SEPN,SERA,SLDB,SLRN,SPRY,SRPT,SRRK,SRZN,STOK,SYK,SYRE,TARS,TDOC,TECX,TMO,TRAW,TRML,TYRA,UNH,UPB,URGN,VIGL,VRDN,VRTX,VSTM,VTRS,XENE,XNCR,ZNTL,ZYME Closed: ARCT,ARDT,BMRN,CATX,EDIT,EVH,IMRX,IRTC,JSPR,LCTX,LYEL,MEDP,MIST,MRK,MRSN,NKTR,OMER,PEN,PRCT,RGNX,RLMD,TRIB,UHS,VERU,VRCA,VYNE,YMAB,ZBIO Decreased: ABCL,ACLX,ACRV,AGIO,ALKS,ALMS,ALNY,ALXO,APGE,ARGX,ARQT,ARVN,ATYR,AVBP,AVIR,AXSM,BCRX,BCYC,BDSX,BHVN,BIIB,BMEA,BNTX,BSX,CADL,CBLL,CCCC,CDTX,CERS,CNTA,CRBP,CRDF,CRNX,CRSP,CTNM,CYTK,DNA,DRUG,DSGN,ELEV,ENGN,ENTA,EOLS,EXAS,FATE,FBRX,FHTX,FOLD,FTRE,FULC,GBIO,GH,GILD,GMAB,GOSS,GRAL,HOOK,HRMY,HROW,IBRX,ILMN,IMTX,IOVA,IPSC,ISRG,IVVD,JAZZ,KRYS,LEGN,LPTX,LXEO,MIRM,MLYS,MNMD,MREO,NBIX,NBTX,NMRA,NUVL,NVAX,NXTC,OCUL,OLMA,OPRX,OPT,PACB,PASG,PEPG,PMVP,PODD,PRAX,RAPT,RCKT,RXRX,RYTM,SANA,SEER,SLNO,SNDX,SWTX,TARA,TCRX,TGTX,THC,THRD,TNGX,TRVI,TVTX,TXG,UTHR,VERA,VERV,VIR,VKTX,VRNA,VTYX,XOMA Unchanged: ABOS,ABSI,ABVX,ACAD,ACRS,ADAP,ADCT,AFMD,ALDX,ALEC,ALT,ANRO,AORT,APLT,APYX,ARWR,ATHA,ATXS,AVR,BCAB,BCAX,BDTX,BLFS,BOLD,BOLT,CDNA,CMMB,CNTX,CRVS,DAWN,DBVT,DNLI,DTIL,ELDN,ENSC,EPIX,EYPT,GLYC,GSK,HLVX,HOWL,IBIO,IDXX,IKT,IMUX,INBX,INO,IVA,KZR,LENZ,LLY,LNTH,LSB,LYRA,MGNX,MGTX,MNKD,MNPR,MOLN,NAUT,NLSP,NPCE,NSPR,NTLA,NUVB,OABI,OBIO,OVID,PBYI,PHGE,PHVS,PRLD,PRME,PRTA,QTTB,ROIV,RPTX,RXST,RZLT,SABS,SCPH,SGMT,SIBN,SKYE,SMMT,SNY,TBPH,TENX,TERN,TIL,TNYA,TRDA,TSBX,TSHA,UNCY,VCYT,VNDA,VOR,VTVT,VYGR,WGS,WVE,XERS,XTNT,ZLAB,ZURA